Novel antimicrobial restorative materials

for the control of dental disease by Everett, Elen
Novel Antimicrobial Restorative Materials
for the Control of Dental Disease
A thesis submitted to Cardiff University
for the degree of Doctor of Philosophy
2018
Elen Pierce Everett
School of Dentistry
Declaration
This work has not been submitted in substance for any other degree or award at this
or any other university or place of learning, nor is being submitted concurrently in
candidature for any degree or other award.
Signed: (Elen Pierce Everett) Date: 9 May 2018
Statement 1
This thesis is being submitted in partial fulfillment of the requirements for the degree
of PhD.
Signed: (Elen Pierce Everett) Date: 9 May 2018
Statement 2
This thesis is the result of my own independent work/investigation, except where
otherwise stated. Other sources are acknowledged by explicit references. The views
expressed are my own.
Signed: (Elen Pierce Everett) Date: 9 May 2018
Statement 3
I hereby give consent for my thesis, if accepted, to be available for photocopying and
for inter-library loan, and for the title and summary to be made available to outside
organisations.
Signed: (Elen Pierce Everett) Date: 9 May 2018
ii
i fy Nhad
Acknowledgements
Pursuing my PhD has been an incredible challenge and it would not have been pos-
sible without the help and support of those around me. Firstly, I owe a huge deal of
gratitude to my supervisors for giving me the opportunity to carry out this project:
Prof. Alastair Sloan, Dr. Alison Paul, and Prof. Rachel Waddington. Their knowl-
edge and advice has been invaluable in guiding my work and their door has always
been open to me. Their encouragement and positivity has often been an antidote to
my pessimism, and has inspired me to pursue a research career beyond my PhD.
I am grateful to my colleagues in the schools of Dentistry and Chemistry for all their
support. In particular Dr. Wayne Ayre, for his training and advice; Dr. Genevieve
Melling, for sharing my liposome-related woes; and Josh Twigg, who contributed clin-
ical skill and expertise to part of this work. Hayley Pincott and Sue Wozniak have
been of great help in the pathology lab, as has the advice of Dr. Adam Jones. I am
also grateful for all the technical support from Lucy Marsh and Dr. Sarah Bamford
in the microbiology lab, and from Dr. Rob Jenkins in the School of Chemistry. There
have been many others who have lent a hand, an ear or a piece of equipment along
the way, and I am very lucky to have worked with such a supportive group of people.
Daily life in the lab has been (mostly) made a joy by my wonderful friends: Dan,
Emma, Clotilde, Josh, and of course my work wife Dally, who has never failed to
brighten up my day through our 4 years of postgrad together. Together we’ve laughed
(a lot), cried (a bit), and gotten through a ridiculous amount of coffee and crosswords.
Yr wyf wedi derbyn gymaint o gefnogaeth gan fy ffrindiau a fy nheulu. ’Rydych
wedi codi fy nhgalon bob tro ddof adra, ac wedi tynnu fy sylw oddi wrth straen y
PhD at bethau pwysicach fel cerdded y cwˆn ar y traeth, croesawu babis newydd i’r
byd, a gwario amser gwerthfawr hefo’n gilydd. In particular, thank you to Nain and
Taid for their constant support; my sister Sarah and my brother Rhys, for never
letting me get ideas above my station; Nigel, for his support and kindness; and to
my Mam, whose strength inspires me every day. She has always encouraged me to
be myself and to face life’s challenges with determination and a sense of humour.
No words can express the contribution of my best friend and husband, Ali. Thank
you for your endless love and patience, and for always believing in me, even when I
don’t. Dwi’n caru ti.
iv
Funding & Presentations
This project was generously supported by a Health and Care Research Wales PhD
studentship.
Work from this thesis has been presented at the following meetings:
Speaking of Science, Cardiff, May 2015
“Controlling Dental Disease with Jelly”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
BSODR annual general meeting, Cardiff, September 2015
“Antimicrobial hydrogels for the control of pulpal disease”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
CITER 3rd South West Regional Regenerative Medicine Meeting,
Bristol, September 2015
“Antimicrobial hydrogels for the control of pulpal disease”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
Cardiff Chemistry Conference, Cardiff, May 2016
“Antimicrobial Hydrogels For The Control Of Dental Disease”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
Poster prize winner, 2nd place
TCES meeting, London, July 2016
“Antimicrobial hydrogels for the control of pulpal infection to facilitate regener-
ative endodontics”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
M4 Colloids Symposium, Bath, July 2016
“Antimicrobial hydrogels for the control of pulpal infection to facilitate regener-
ative endodontics”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
Chemistry: The science around us, Sheffield, July 2016
“Antimicrobial hydrogels for the control of dental disease”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
CITER annual scientific meeting, Cardiff, September 2016
“Antimicrobial hydrogels for the control of dental disease”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
v
School of Medicine and Dentistry Postgraduate Research Day, Cardiff,
November 2016
“Development of an Antimicrobial Hydrogel to Manage Dental Disease”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
IADR General Session, San Francisco, March 2017
“An antimicrobial hydrogel for the control of root canal infections”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
IADR General Session, San Francisco, March 2017
“Physical analysis of an injectable hydrogel for endodontic drug delivery”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
M4 Colloids Symposium, Cardiff, July 2017
“An injectable hydrogel for antimicrobial delivery to dental root canals”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
BSODR annual general meeting, Plymouth, September 2017
“A novel, injectable hydrogel for endodontic antimicrobial delivery”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
CITER annual scientific meeting, Cardiff, September 2017
“A novel, injectable hydrogel for endodontic antimicrobial delivery”
Elen P Everett, Rachel Waddington, Alison Paul, Alastair J Sloan
Winner, best oral presentation
vi
Abstract
Recurrence and persistence of microbial infection is one of the main reasons for the re-
vision of dental restorations in the clinic. Failure to control the pathogenic microbiota
leads to the formation of caries, which in turn may lead to irreversible pulpal dam-
age, resulting in the need for root canal (endodontic) therapy. Secondary endodontic
infections can spread to the surrounding oral tissues and beyond, leaving the patient
vulnerable to systemic infection. This project aimed to develop a novel, injectable
hydrogel containing antimicrobial liposomes for use as an intracanal medicament in
order to reduce the incidence of secondary endodontic infections.
Triclosan, a broad-spectrum, hydrophobic antimicrobial drug, was shown to have a
bacteriostatic and bactericidal effect against two oral pathogens, Enterococcus faecalis
and Streptococcus anginosus, which were grown planktonically and as a single-species
biofilm. The bacteriostatic effect was also seen when triclosan was encapsulated in
multilamellar vesicles (MLVs) and small unilamellar vesicles (SUVs) of phosphatidyl-
choline:cholesterol (PC:C) liposomes. Antimicrobial efficacy was associated with a
high drug:lipid ratio in the liposomes.
The liposomes were incorporated into a methyl cellulose (MC) solution, and the
rheological properties were measured. MC was a sheer-thinning, viscous solution
at ambient temperature and formed a hydrogel as the temperature was increased
above 30 ◦C. These properties were unaffected by the addition of liposomal MLVs
or SUVs. The hydrogels containing triclosan-loaded liposomes had an antimicrobial
effect when incubated in contact with suspensions of E. faecalis or S. anginosus, but
MC containing triclosan only did not. A release assay showed the release of triclosan
from MC loaded with triclosan liposomes, which was not seen when triclosan was
incorporated into MC alone.
The liposomal hydrogel was injected into endodontically prepared extracted hu-
man teeth that had been inoculated with E. faecalis suspension to mimic endodontic
infection. After 24 h treatment, histological analysis showed that triclosan solu-
tion, triclosan liposomes and triclosan liposomes in MC prevented the formation of
a biofilm on the intraroot surface, which was observed in controls that underwent no
treatment or treatment with MC hydrogel only.
The results of this work indicated that triclosan liposomes have potential to pre-
vent secondary endodontic infections and may be loaded into a hydrogel suitable for
injection into the root canal and subsequent gelation upon thermoequilibriation with
the oral cavity. Triclosan release from this hydrogel may facilitate the prevention of
bacterial colonisation of the root canal by E. faecalis, which has high prevalance in
secondary endodontic infections.
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Chapter 1
General Introduction
1.1 Introduction
Persistence and recurrence of polymicrobial infections in the tooth are common rea-
sons for the failure of dental restorations, including endodontic (root canal) fillings
(Bernardo et al., 2007; Tabassum and Khan, 2016). Most dental infection begins with
the formation of caries (tooth decay) on the tooth’s enamel, and this leads to the
exposure of internal dental tissues to the oral cavity, which in turn can allow for the
invasion of bacteria into the dental pulp. Pulpal infection leads to irreversible damage
and necrosis of the pulpal tissue and the remaining cavity becomes a reservoir for
bacteria and their by-products. Infection can spread to the surrounding periodontal
tissues, leading to tooth loss and the risk of systemic infection. Tooth loss may have
a significant impact on an individual’s quality of life: causing social and aesthetic
embarrassment, poorer diet, problems with speech and deterioration of the surround-
ing oral tissues (Saintrain and de Souza, 2012). Treatment of pulpal disease poses
significant challenges and it is often necessary to perform endodontic treatment: re-
moving the entirety of the dental pulp and replacing it with an inert material. This
treatment is technically challenging, time-consuming and costly to the NHS and to
individual patients. The NHS in England and Wales annually spend around £266
million providing around 12 million dental restorations, many of which are replacing
failed restorations from previous treatment (Lynch and Wilson, 2013). The 10-year
1
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survival rate of dental restorations is around 50 %, with root fillings having a shorter
life span than other restorations (Burke et al., 2005; Lucarotti et al., 2014). Failure
is usually due to the persistence of microbial infection that was not eradicated dur-
ing treatment or the recurrence of infection (secondary infection) following bacterial
leakage around the restoration. Currently, the use of antimicrobial materials is lim-
ited in dental treatment and systemic antibiotics are not effective in treating pulpitis
or periodontitis. There is therefore a need to develop new therapeutic treatments
that can control dental infection and prevent re-infection, thus extending the life of
the restoration. This project aims to build on previous work in developing a den-
tal restorative material that has effective antimicrobial properties. Ultimately, this
material should aim to:
1. Limit bacterial re-infection following restorative dental treatment and reduce
the number of restorations that fail due to secondary infection;
2. Reduce the need for further and more complex treatment or tooth extraction;
3. Reduce the need to use systemic antibiotics, which are often ineffective against
the polymicrobial infections found in the tooth;
4. Reduce the cost of dental restorations to the NHS as well as individual patients.
Specifically, the project will aim to achieve controlled release of a broad-spectrum
antimicrobial at a clinically significant dose from a novel restorative material. This
material will be a biocompatible hydrogel that can incorporate liposomal triclosan,
so a 2-tier delivery mechanism is employed, both from the liposomes and from the
gel itself. Previous work has demonstrated that liposomes containing triclosan can
prevent and treat infection by Streptococcus anginosus in an ex vivo rat pulp infection
model and that liposomal triclosan is more effective than the drug alone. It has also
been incorporated into glass ionomer cement, a material commonly used in dental
restorations (unpublished). This project aims to build on this work by further char-
acterising triclosan release from liposomes and assessing their effect on endodontic
infections ex vivo, by developing a human root canal infection model. It will also aim
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to introduce the liposome into hydrogel systems and assess the rheological and drug
release properties of these formulations.
1.2 Dental function and anatomy
1.2.1 Function of teeth
Human teeth primarily function to mechanically prepare food for digestion, although
they also play an important role in speech. Aesthetically, teeth are important and are
often visually referred to in order to judge another persons attractiveness and general
hygiene (liana Eli et al., 2001). Humans develop 2 sets of teeth in their lifetime, and
therefore the secondary, permanent dentition must have longevity. The tooth must be
hard and well rooted in order to perform its function. Enamel, the outer layer of the
tooth, is the hardest tissue in the body but is also very brittle. It is supported by the
less mineralised dentine layer, which is produced and maintained by the dental pulp.
The teeth are kept firmly attached to the jaw bones by the periodontal ligament, as
shown in Figure 1.1 (Nanci, 2013).
1.2.2 Enamel
Enamel is the protective material of the crown of the tooth and its maintenance
and/or repair is key to maintaining dental health (Featherstone, 2000). Enamel is
produced by ameloblasts, which reside on the dentine-enamel junction of the develop-
ing tooth and regulate the secretion of a layer of proteins and proteinases, including
amelogenin and enamelin (Gallon et al., 2013). These proteins will then control the
nucleation, growth and organisation of hydroxyapatite crystals, forming a highly or-
dered, mineralised tissue (Iijima et al., 2010). Mature enamel is composed of around
96 % hydroxyapatite crystals, with the rest consisting of water and organic matter.
After enamel is formed, it cannot be regenerated naturally, due to the loss of
ameloblasts after tooth development. Many ameloblasts undergo cell death by apop-
tosis and regression, and the remaining cells are either shed during tooth eruption,
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Figure 1.1: Anatomy of human tooth and surrounding tissues. Illustration
adapted from Nanci (2013)
.
or incorporated into the tooth’s epithelial attachment to the oral gingiva (Lacruz
et al., 2017). It has been shown that enamel can be produced in vitro from adult
human gingival epithelial cells and contains ameloblast-like cells, confirmed by histol-
ogy, micro-computed tomography (micro-CT) and immunohistochemistry for human
major histocompatibility complex (MHC) class 1 protein (Angelova Volponi et al.,
2013).
Enamel is relatively impermeable but can be affected by acid produced by plaque-
dwelling bacteria. The organic enamel matrix surrounding the apatite crystals has
a relatively high water content and so it is permeable to hydrogen ions (Cawson
and Odell, 2008). This causes acid erosion of enamel and the development of dental
caries, which is one of the most prevalent chronic diseases of humans worldwide
(Selwitz et al., 2007).
CHAPTER 1. GENERAL INTRODUCTION 5
1.2.3 Dentine
Below the enamel lies another mineralised layer, dentine, which forms the bulk of
the tooth and provides structural support. Dentine is produced by pulpal cells, the
odontoblasts, which unlike ameloblasts will remain as a constant source of dentine
production for the lifespan of the tooth (Couve, 1986; Sloan et al., 1998; Sloan and
Waddington, 2009). Odontoblasts are tall, columnar cells located at the periphery
of the dental pulp. They derive from ectomesenchymal cells originated by migration
of neural crest cells during the early craniofacial development (Nanci, 2013). During
dentine production (detinogenesis), they initially secrete a matrix (predentine) con-
sisting of collagenous (primarily collagen type I) and non-collagenous proteins. The
odontoblasts then control the mineralisation of this matrix, resulting in tissue com-
posed of around 50 % v/v mineral (mainly hydroxyapatite); 30 % v/v organic matter
(largely type I collagen); and about 20 % v/v fluid, which is similar to plasma and
contains albumin, fibrinogen and immunoglobulin G (IgG) (Knutsson et al., 1994;
Marshall et al., 1997). Primary dentinogenesis occurs during tooth development and
involves relatively rapid dentine production. Secondary detinogenesis occurs after
tooth eruption and is characterised by a lower rate of deposition and a different gene
expression profile, including the up-regulation of matrix proteins osteocalin and den-
tine matrix acidic phosphoprotein-1 (DMP-1) and down-regulation of collagen type
I and dentine sialophosphoprotein (DSPP), among others (Simon et al., 2009).
As dentine is formed, the odontoblasts leave behind cell processes, which form the
scaffold for tubule formation within the dentine. These long tubules follow the path
of the progressing odontoblasts which make dentine a hard but highly porous tissue.
Fibrillar structures are present within the tubules, which were originally posited to be
branches or ramifications of the odontoblast processes (Szabo et al., 1984), but have
more recently been suggested to anchor the odontoblast processes inside the tubules
(Garce´s-Ort´ız et al., 2015). It has been observed that the odontoblast processes
can extend through the entire thickness of the dentine, up to the dentine-enamel
junction (Fox et al., 1984) . The presence of the odontoblast process makes dentine
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a vital tissue that can respond to external stimuli such as pressure and temperature
(Pashley et al., 1981; Camps and Pashley, 2003). The porous structure of dentine has
important implications in pathogenesis. Without the protection of the enamel, the
dentine is readily permeable to bacteria and their products, which can then progress
to the pulp, causing inflammation and infection known clinically as pulpitis. The
collagen-rich nature of both dentine and pulp allows for the attachment of bacteria
posessing collagen-binding proteins, such as some Streptococcus species (Avile´s-Reyes
et al., 2017).
1.2.4 Pulp
Pulp is a non-mineralised connective tissue that resides in the centre of the tooth
in the pulpal chamber. It consists mainly of fibroblasts, with the dentine-forming
odontoblasts lining the periphery. It also contains blood vessels, nerves and a number
of other cell types, including immune cells and mesenchymal progenitor cells. The
progenitor cells are pluripotent and can differentiate into a number of cell types
including odontoblasts (Gronthos et al., 2002).
Pulp fibroblasts secrete an extracellular matrix (ECM) consisting mainly of col-
lagens type I and III and glycoproteins such as chondroitin sulphate and hyaluronic
acid (Goldberg and Smith, 2004). The ECM acts as support for the fibroblasts and
also mediates many of the cellular interactions, as cell metabolites, nutrients and
waste pass through the matrix between the different cell types present in the pulp.
In incidences of pulpitis, the matrix can act as a source of nutrients for invading bac-
teria, whilst the collagen components provide an anchor to which many bacteria can
attach, as previously mentioned (Section 1.2.3). Roberts et al. (2013c) found that
Streptococcus anginosus group bacteria could attach directly to dental pulp when
co-cultured with rat tooth slices ex vivo. Additionally, the ECM directly adjacent
to these showed signs of degradation, possibly due to the bacteria’s synthesis of en-
zymes hyaluronidase and chondroitin sulfatase (Jacobs and Stobberingh, 1995). This
highlights the importance of preventing bacterial infiltration into the pulpal chamber
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in order to prevent destruction and necrosis of the tissue.
1.2.5 Dentine-pulp complex
Anatomically, dentine and pulp are distinguishable from one another due to differ-
ences in their structure and mineralisation, but they are functionally and embryolog-
ically considered together as the dentine-pulp complex. Pulp produces the dentine
that surrounds it and also produces new dentine when required. The pulp also nour-
ishes the avascular dentine and it is the nerves of the pulp that give the dentine its
sensitivity in order to react to external stimuli. The odontoblasts act as the pulp’s
first line of defence, with processes that line the dentinal tubules able to sense the
presence of bacteria and trigger an immune respose from the pulp before the bac-
teria have reached the pulpal chamber. This was investigated by Veerayutthwilai
et al. (2007), who cultured tooth crowns with their odontoblasts ex vivo and ob-
served that odontoblasts can identify and differentiate between Gram-positive and
Gram-negative bacteria through toll-like receptors 2 and 4 (TLR2/TLR4) to initi-
ate an immune response. One response is the rapid secretion of dentine, known as
tertiary dentinogenesis.
1.2.5.1 Tertiary dentinogenesis
The dynamic nature of the dentine-pulp complex can be seen during pathogenesis.
Injury or infection of the tooth leads to the exposure of the dentine-pulp complex to
the oral cavity and leaves it susceptible to further infection and tissue damage. The
pulp reacts by producing new dentine termed tertiary dentine. Tertiary dentine is
different from primary and secondary dentine (Section 1.2.3) in that it is produced
as a result of an environmental stimulus. Its structure depends on the severity of the
stimulus and the speed at which the dentine matrix is secreted, with some examples
being barely distinguishable from primary or secondary dentine, and other examples
having a highly irregular, atubular structure, with cells trapped within it (Smith
et al., 2003). In cases of rapidly progressing dental caries, tertiary dentinogenesis
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may not take place at all (Bjørndal, 2001).
There are 2 types of tertiary dentinogenesis, as defined by Smith et al. (1995):
Reactionary dentinogenesis is performed by post-mitotic odontoblasts that
survive the initial injury or infection.
Reparative dentinogenesis occurs when a new generation of odontoblasts
develop from progenitor cells in response to the death of the original odonto-
blasts.
Reactionary dentinogenesis is considered to be a similar process to primary dentino-
genesis, as it is simply an up-regulation of the events that occur during tooth devel-
opment (Smith and Lesot, 2001). It is only the source of the stimulus that is different
between both events, however in some cases this may be similar too. The stimuli for
reactionary dentinogenesis include growth factors such as transforming-growth factor
β (TGFβ). TGFβ may be expressed by odontoblasts throughout the lifetime of the
cells (Sloan et al., 2000), and is believed to be sequestered by dentine as it has been
found to be present using a bioassay (Finkelman et al., 1990). Upon carious deminer-
alisation of the dentine, this growth factor is solubilised and can act as a trigger for
the up-regulation of dentine matrix secretion by the odontoblasts (Tziafas and Pa-
padimitriou, 1998). As well as similar stimulatory molecules, it is also suggested that
reactionary dentinogenesis is mediated by similar processes to primary dentinogensis.
Simon et al. (2010) stimulated odontoblast-like cells with Streptococcus mutans, as
well as growth factors known to stimulate reactionary dentinogenesis, to investigate
this. They observed activation of the p53 mitogen-activated protein kinase (MAPK)
pathway, which is also active during primary (but not secondary) dentinogenesis.
Reparative dentinogenesis is a more complex process than reactionary dentino-
genesis: it requires division, migration and differentiation of pulp progenitor cells
to occur, in order to replenish the odontoblast layer that is lost due to significant
trauma (Cooper et al., 2010). These processes are mediated by a host of signalling
molecules, including members of the TGFβ family and bone morphogenic proteins
(BMPs), as reviewed by (Kim, 2017). The range of regenerative responses is diverse
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and dependent on the severity of the trauma, resulting in a range of dentine mor-
phologies (Smith et al., 2005). Reparative dentine is even disputed to be true dentine
by some: Ricucci et al. (2014) histologically examined human teeth that had been
exposed to different levels of trauma, and suggested that the reparative dentine was
in fact more akin to a calcified scar tissue produced by pulpal fibroblasts, due to
the lack of tubules and the absence of odontoblast-like cells adjacent to the calcified
tissues.
Both reactionary and reparative dentinogenesis ultimately involve the rapid se-
cretion of a dentine matrix in order to create a physical barrier between the pulp
and the negative stimulus, such as microbial invasion. Where this process fails, the
pulpal cells are exposed to infection and react to this in an inflammatory response.
1.2.5.2 Pulpal inflammation
Pulpal inflammation occurs as a result of the infiltration of bacteria and/or their
products into the dentine-pulp complex. As previously stated (Section 1.2.3), molec-
ular attachment to TLRs on the odontoblast processes induces an immune response
but a response can also be induced before direct bacterial contact, through the acid
erosion of dentine and the release of growth factors such as TGFβ (Section 1.2.5.1).
Bacterial lipopolysaccharide (LPS) also plays a significant role in the dentine-pulp
immune response. LPS is a major component of the bacterial cell wall and is found
in almost all Gram-negative bacteria, including those associated with dental caries
(e.g Veillonella spp.). It is released during cell multiplication and cell death, and
has been shown to persist in dentine even after clinical disinfection of the tooth,
where dentine is no longer positive for microbial growth (Vianna et al., 2007). LPS
induces the secretion of pro-inflammatory cytokines from the the pulpal cells, includ-
ing tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8)
(Nagaoka et al., 1996; Kent et al., 1999; Fouad and Acosta, 2001).
Macrophages and neutrophils are the cells that mediate the innate immune re-
sponse in pulp, as in other tissues (Hahn and Liewehr, 2007). B and T cells of the
acquired immune system are later recruited as inflammation progresses. These cells
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secrete pro-inflammatory cytokines as well as tissue degrading enzymes such as matrix
metalloproteinases (MMPs), which mediate the destruction of pulpal tissues. This
response is essential in driving repair processes such as tertiary dentinogenesis, as
previously discussed (Section 1.2.5.1). A prolonged immune response, however, will
lead to irreversible tissue necrosis, through accumulation of tissue-degrading enzymes
(Colombo et al., 2014). Additionally, it has been shown that tertiary dentinogenesis
mediated by TGF-β and BMP-7 only occurs in the absence of LPS-induced inflam-
mation in a ferret model of pulpitis, suggesting that the inflammatory response must
be ameliorated before reparative processes can take place (Rutherford and Gu, 2000).
As in most tissues, the balance between inflammation and repair in the dentine-pulp
complex is a delicate one. Paula-Silva et al. (2009) showed that TNF-α promoted
an odontoblastic phenotype in pulpal stem cells in vitro as well as down-regulating
MMP-1 expression. Long-term TNF-α exposure, however, was suggested to inhibit
tooth remineralisation long-term by Min et al. (2006), who cultured pulpal cells with
TNF-α and observed initially high activity levels of the pro-mineralisation protein
alkaline phosphatase (ALP), which then decreased with longer-term exposure. Clini-
cally, it is therefore important that inflammation can be controlled by removal of the
microbial presence at the site of infection in order to avoid long-term exposure of the
pulp to a pro-inflammatory environment and allow regeneration to occur.
1.3 Microbiology of pulpitis and root canal infec-
tion
The oral cavity contains hundreds of bacterial, viral and fungal species, which nor-
mally exist as commensal organisms. Environmental changes induced by diet, oral
hygiene habits, or the health status of an individual, however, can induce a pathogenic
phenotype in some microbial species (Marsh, 1994). Specifically, it can lead to ex-
cessive secretion of acidic bacterial by-products, which erode the dental enamel and
cause dental caries. This exposes the dentine-pulp complex to the oral cavity, its
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bacteria and their by-products, causing pulpal inflammation (termed clinically as
pulpitis).
The microbial population of an advancing carious lesion changes as infection pro-
gresses through the different environments of the enamel, dentine and pulpal tissues.
Most notable is the transition from predominantly facultative Gram-positive bacte-
ria in early caries to anaerobic Gram-positive bacilli and cocci, and Gram-negative
bacilli in deep, carious lesions (Hoshino, 1985). The infection is difficult to treat due
to its dynamic, polymicrobial nature, and failure to control this infection leads to it
spreading to the periapical tissues and beyond (see Figure 1.2).
1.3.1 Dental plaque
The enamel is the only non-shedding tissue in the human body and so provides a
uniquely stable surface for microorganisms to attach and adhere to. The presence of
microorganisms as a surface-bound colony (as opposed to a planktonic suspension)
is known as a biofilm and dental plaque is the biofilm that resides specifically on
the enamel surface of a tooth. Plaque is composed of commensal bacteria and, in a
healthy environment, acts to prevent colonisation by exogenous and/or pathogenic
microorganisms (Marsh and Bradshaw, 1995). The development of caries depends on
the formation of plaque and its modulation to allow for acid erosion of the enamel.
Plaque formation normally begins with the deposition of the pellicle: a cell-free
layer of salivary proteins that will coat a clean tooth within 90-120 s (Marsh and Brad-
shaw, 1995). Its composition has been characterised using proteomic techniques such
as mass spectrometry, and is found to contain antimicrobial molecules (lysozyme C),
anti-inflammatory molecules (S100-A8, S100-A9), Ca2+ binding proteins (α-amylase
1, S100 proteins), and crosslinking enzymes (transglutaminase 3), amongst others
(da Silva Ventura et al., 2017; Delius et al., 2017). The relative quantities of these
proteins in the pellicle differs to those in the surrounding saliva and it has been sug-
gested that proteins are selectively adsorbed to enamel, serving to promote healthy
biofilm development, as well as protection of the enamel from acid erosion (Hannig
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Figure 1.2: Sequelae of pulpitis. Adapted from Cawson and Odell (2008)
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and Joiner, 2006).
Initial microbial pellicle colonisation is a passive process, with bacteria passing
the pellicle through salivary flow and attaching via non-specific, reversible physico-
chemical forces (Busscher et al., 1992). The pellicle is then quickly colonised (within
24 h) by adherent bacteria posessing cell surface adhesins. (Cawson and Odell, 2008).
It was observed by Nyvad and Kilian (1987) using biochemical identification, that
non-mutans Streptococcus spp. dominated the early plaque formed on enamel pieces
carried in the human oral cavity. The mechanism for their early adhesion is thought
to be through lectin-like proteins on the bacterial cell wall that bind to pellicle-
associated glycoproteins (Shibata et al., 1980). Li et al. (2004) observed that Actino-
myces species are the predominant plaque species after 2 h of biofilm formation, with
Streptococcus oralis and S. mitis dominating after 6 h. The ability to interact with
both the pellicle and other bacteria is crucial to the development and maturation of
the biofilm. Actinomyces spp. possess cellular projections known as fimbriae, and
Cisar et al. (1984) used adhesion and co-aggregation assays to show that there are 2
distinct functional types: type 1 fibrimae recognise and bind to salivary proteins and
type 2 are associated with a lectin-like interaction with streptococci. Jenkinson et al.
(1993) identified a large protein of S. gordonii that interacts with salivary proteins
of the pellicle as well as a receptor on the surface of A. naeslundii. The function of
the protein was confirmed by silencing the gene that encodes for the protein, and
observing a decrease in adhesion to the 2 structures.
After initial attachment, bacteria continue to colonise the plaque, attaching to sur-
faces and each other. Fusobacterium spp. are considered to be critical in bridging the
gap between early and late-colonising bacteria as they can adhere to and co-aggregate
a wide range of bacterial species, although the mechanism for this is not fully known
(Kolenbrander et al., 2006). Late colonisers of dental plaque include A. actino-
mycetemcomitans, Prevotella intermedia, Eubacterium spp., Treponema spp., and
Porphyromonas gingivalis (Kolenbrander et al., 2002).
Plaque formation also involves the bacterial production of extracellular polysac-
charides (EPS). Oral bacteria have been shown to synthesise dextrans (including
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poorly water-soluble α-D-glucans) and levans using sucrose as a substrate (Suther-
land, 2001). EPS contributes to the structural integrity of the biofilm, as well as
its pathogenic properties. The increased pathogenicity of biofilms with higher EPS
content was suggested by Dibdin and Shellis (1988), who observed that EPS-rich
biofilms of S. mutans allowed for greater sucrose retention, and posited that this
would allow for deeper sucrose penetration into dental plaque, resulting in a lower
pH at the plaque-enamel interface. This was supported by a study comparing the
effect of different ratios of S. mutans to EPS, which found that demineralisation of
experimental enamel slides was greatest when the artificial plaque consisted of 95 %
EPS and 5 % bacteria (Zero et al., 1986).
The transition from health to pathology in the dental plaque is mediated by a
number of factors, the most widely recognised being the intake of dietary sugars
(Leme et al., 2006). Increased sucrose in the oral cavity leads to an increase in EPS
production and its previously mentioned caries-promoting effect. This is exacerbated
by poor oral hygiene, where the absence of tooth brushing to disrupt the plaque allows
for the formation of a mature, EPS-rich biofilm. An increase in biofilm density allows
for the formation of microenvironments with lower pH and oxygen concentration than
the oral cavity, which are protected from the buffering effects of saliva (Cawson and
Odell, 2008). It is here that anaerobic, acid-tolerant bacteria may thrive and out-
compete other plaque species, leading to a decrease in overall plaque biodiversity and
an increase in caries-causing bacteria (Marsh and Zaura, 2017).
1.3.2 Dental caries
Dental caries is the demineralisation of enamel and/or dentine by bacterially-produced
acid (primarily lactic acid). This depends on the presence of acidogenic bacteria
within dental plaque, which are also tolerant of the low local pH in the biofilm. The
dense structure of the dental plaque allows for the maintenance of an acidic environ-
ment that is not easily penetrated by salivary buffers, therefore exposing the enamel
to a continuously low pH (Cawson and Odell, 2008). S. mutans and Lactobacillus
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spp. survive better in low pH conditions than non-mutans Streptococcus spp. and
Actinomyces spp. and so their presence becomes more prevalent in the carious biofilm
(Horiuchi et al., 2009). Some bacterial species, such as Veillonella spp. can utilise
lactic acid and convert it to weaker acid: Van der Hoeven et al. (1978) observed a re-
duction in caries and lower plaque lactate in rats infected with Veillonella alcalescens
and S. mutans compared with S. mutans alone.
The initial stages of caries are subsurface, with the topmost layer of enamel re-
maining intact and demineralisation occuring beneath the surface. This is known
clinically as a white spot lesion and is believed to be a result of a higher degree of
mineralisation in the surface of enamel compared to the subsurface, which results
in the initial resistance of the surface enamel to demineralisation (Hallsworth et al.,
1972). As demineralisation progresses, the enamel becomes more porous and so acid
can diffuse more freely into the matrix, thus accelerating the process.
Whereas S. mutans is prevalent in cavitated enamel lesions, the advancing front of
dentine caries contains more Lactobacillus spp., Prevotella spp. and Bifidobacterium
spp. (Takahashi and Nyvad, 2011). Despite the apparent importance of S. mutans
and lactobacilli in the progression of dental caries, Boyar et al. (1989) found examples
of carious lesions with no evidence of these species present in extracted teeth that were
banded to allow plaque growth ex vivo, suggesting that these species are not essential
to instigate caries formation. Simo´n-Soro et al. (2014) used metatranscriptomics to
compare microbiomes sampled from enamel caries and dentine caries, and found that
biodiversity increased in the dentine, although the reason for this is unclear. The
presence of anaerobic bacteria in carious dentine of extracted teeth were detected
by Martin et al. (2002) using real-time polymerase chain reaction (PCR), and the
presence of Micromonas micros (now named Parvimonas micra) and Porphyromonas
endodontalis correlated with the development of irreversible pulpitis and endodontic
infections that occurred as a result of carious pulpitis. P. endodontalis is a virulent
anaerobe, that was shown by Mirucki et al. (2014) to possess novel complex lipids
that induce TNF-α expression in macrophages in vitro. P. micra is accociated with
symptoms of throbbing pain in irreversible pulptitis (Roˆc¸as et al., 2015) and some
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strains have been shown, through biochemical testing, to produce collagenase, which
could account for its destructive nature in the collagen-rich pulp tissue (Ota-Tsuzuki
and Mayer, 2010).
Once caries has progressed to the dentine, the dentine-pulp complex is exposed
to the oral cavity. As previously discussed (Section 1.2.5), odontoblasts and their
processes recognise bacteria, bacterial LPS, and growth factors released from the
demineralised dentine, and initiate an immune response. The dentine-pulp complex
can also inhibit movement through the tubules by depositing minerals within the
tubules to reduce their size and permeability in a process known as tubular sclerosis
(Kidd and Fejerskov, 2004). This reaction may slow progression, but even sclerotic
dentine is vulnerable to bacterial acid and can eventually be penetrated by bacteria.
1.3.3 Pulpal and periapical infection
Infection of the pulp triggers the production of tertiary dentine, as well as stimula-
tion of the immune response, as previously discussed (Sections 1.2.5.1 and 1.2.5.2).
Prolonged stimulation of the immune response alongside the destructive nature of
certain microbial species (e.g. those that secrete collagenases), however, may lead to
irreversible pulpal damage and necrosis.
Once necrosis of the pulp has occurred, it is possible for bacteria to colonise the
internal dentine surfaces as a biofilm, as first observed by Nair (1987) using trans-
mission elecron microscopy (TEM) on extracted carious teeth with periapical lesions.
The composition of the biofilms are dependent upon the niche in which they reside
and Cha´vez de Paz (2007) defined 3 of these niches as the coronal segment (nearest
the crown), main canal, and the apical segment (tip) of the root canal (Figure 1.3).
The microbial composition of these biofilms varies due to gradients in environmental
conditions, such as oxygen concentration and nutrient levels, which both decrease
from the coronal to the apical sections. Biofilms that colonise the apical section are
of particular interest, as it is believed that this is the point of access for bacteria
to the periapical tissues surrounding the tooth. Chugal et al. (2011) used molecular
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Figure 1.3: Microbial niches of the dental root canal. Modified from Cha´vez
de Paz (2007).
sequencing techniques to characterise the microbiome of apical root sections of teeth
with necrotic pulp and teeth that had undergone endodontic (root canal) therapy.
They found Fusobacterum spp., Actinomyces spp., and oral Anaeroglobus geminatus
in both types of infection and a general decrease in biodiversity in secondary infec-
tions. Many secondary infections contained Burkholderiales or Pseudomonas spp. as
well as Enterococcus faecalis, all of which are opportunistic environmental pathogens
that were not present in the primary infected tissue. This was in agreement with other
similar studies (Siqueira and Roˆc¸as, 2005; Alves et al., 2009). These studies suggest
that primary and secondary endodontic infections are caused by distinct microbiomes.
Additionally, clinical intervention may not eradicate infection, but rather modulate
the microbiome to a less biodiverse, but selectively resilient community, that contains
opportunistic environmental pathogens with the potential to cause further damage.
Further spread of infection causes a periapical lesion to develop, either in the
form of a periapical granuloma or periapical abscess. This happens when bacteria
within the root canal make contact with periapical tissue via apical foramina (holes
in the root apex through which nerves and blood vessels enter the pulp) (Sasaki and
Stashenko, 2012). These bacteria induce an immune response in the perapical tissues,
leading to tissue liquefaction (through immune cell enzyme secretion) and formation
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of a pus-filled cavity known as an abscess (Shweta, 2013). There is not a single
pathogen that has been identified as causing periapical infection, although certain
species are more prevalent (Robertson and Smith, 2009). The Streptococcus anginosus
group of bacteria, for example, are commonly associated with periapical lesions (Iwu
et al., 1990; Fisher and Russell, 1993). The pathogenicity of S. anginosus is of great
interest as these bacteria have been associated with a number of human infectious
diseases. Asam and Spellerberg (2014) and Sitkiewicz (2017) recently reviewed the
potential virulence factors of S. anginosus group bacteria, including their adhesion
to host cells, β-haemolytic phenotype (the ability to destroy red blood cells), and
secretion of toxic hydrogen sulphide.
Enterococcus spp. are often found in dental abscesses, most commonly E. faecalis,
and particularly in secondary infection sites following dental treatment (Pinheiro
et al., 2003; Roˆc¸as et al., 2004; Stuart et al., 2006). This is due to its survival ability
in high pH conditions, the introduction of which are often relied upon for disinfection
during root canal treatments (i.e. using sodium hypochlorite irrigant or calcium
hydroxide root dressings). It is not clear at what point E. faeclis enters the root
canal. Some report that it is detectable neither as part of normal oral microflora,
nor in advancing dental lesions (Zehnder and Guggenheim, 2009). Wang et al. (2012)
cultured samples from the saliva and root canals of patients with apical periodontitis
and found that the presence of E. faecalis in the root canal was more likely if it was
also found in saliva, but not all patients with E. faecalis in the root canal also had it in
their saliva. Vidana et al. (2011) performed a similar study but found no E. faecalis
in any patients’ saliva samples. Furthermore, the cultured isolates from the root
canals of these patients were genetically compared to E. faecalis from the patients’
gastrointestinal tract, and the bacteria isolated from the two sources were genetically
distinct, suggesting that the root infection was not sourced from the patient’s own
microflora. Studies that use culture-independent molecular techniques, however, have
found E. faecalis to be present at detectable, but not culturable quantities in the oral
microflora, and suggest that it is a commensal organism that is selectively increased in
cases of secondary root canal infection (Portenier et al., 2003; Sedgley et al., 2006).
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Most recently, it has been hypothesised that E. faecalis is introduced to the oral
cavity from food sources, due to shared genetic lineages between organisms isolated
from root canals and food sources (Vidana, 2015; Cha´vez de Paz, 2018).
It is the dynamic and polymicrobial nature of pulpitis and associated conditions
that makes treatment challenging. During the sequelae of pulpitis (Figure 1.2), there
are several points for clinical intervention, although it is ultimately the successful
eradication of microbial infection that determines the treatment efficacy, alongside
other factors.
1.4 Pulpitis and root canal infection in the clinic
In 2010, the global prevalence of untreated dental caries in permanent teeth was
35 %, the most prevalent of all oral conditions (Marcenes et al., 2013). It is this that
leads to pulpitis, which is the most common cause of toothache and loss of teeth in
younger people (Cawson and Odell, 2008). Pulpitis presents clinically as increased
sensitivity in the tooth, discomfort or pain. Treatment depends on the severity of
the condition, which has two clinical classifications. Reversible pulpitis describes
inflammation that may be reversed upon the removal of the external stimulus, such
as caries. In irreversible pulpitis, the damage is more severe and all the dental pulp
must be removed in order to prevent further spread of infection. Recently, biomarkers
for pulpal inflammation have been identified to aid in diagnosis of pulpitis, including
IL-8, MMP-9, TNF-α, and a receptor for advanced glycation end products expression,
according to a recent systematic review (Zanini et al., 2017). Patients are diagnosed
based on a number of factors, including radiographic evidence of caries, history of
pain, sensitivity to hot and cold stimuli, sensitivity to tapping (percussive test) and
sensitivity to electrical currents using an electric pulp test (Meja`re et al., 2012).
Both reversible and irreversible pulpitis, however, may also be asymptomatic. The
mechanism of symptomless pulpitis is not fully understood, but has been associated
with older patients (Farac et al., 2012), with the suggestion that slower progression
may result in the lack of symptoms (Michaelson and Holland, 2002).
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1.4.1 Dental restorations
The treatment of pulpitis usually involves some form of dental restoration. The type
of restoration performed will depend on a variety of factors including the severity of
the condition, the type and position of the affected tooth (and surrounding teeth)
and the age and health status of the patient. Preparation of the tooth prior to the
placement of a restoration includes the removal of infected tissues and any portion
of the tooth that may be structurally unsound. In cases of reversible pulpitis, this
does not include pulp tissue. There are 2 types of dental restoration that may then
be placed:
Direct restorations involve the placement of a restorative material directly
into the tooth. It is done as a single procedure, using a material such as
amalgam, composite resin or glass ionomer cement. These can be moulded in
situ to fill the prepared cavity and seal the tooth.
Indirect restorations must be pre-formed before placement in the tooth and
require multiple clinic visits by the patient. Crowns, inlays and onlays are
examples of indirect restorations. Materials used include porcelain and gold.
The decision to place either direct or indirect restorations may be dictated by the
clinical factors, such as lesion size and aetiology, however patient and dentist prefer-
ence may also factor in (Smithson et al., 2011). Indirect restorations are more costly
than direct restoration, however indirect restorations generally last longer than direct
restorations, as reviewed by Manhart et al. (2004). Despite their increased longevity,
Kelly and Smales (2004) compared the cost-effectiveness of direct and indirect restora-
tions and found that direct restorations remained the most cost-effective restorations
over 15 years and recommended that these be placed in preference to indirect restora-
tions where clinically applicable.
There are a range of materials that are used for dental restorations, each with
advantages and disadvantages. The main criteria for a suitable material include bio-
compatibility, aesthetics and suitable physical properties (e.g. resistance to wear
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and fracture, minimal shrinkage over time). The overall clinical success of a restora-
tion, however, is multi-factorial and therefore difficult to predict based on physical
properties alone (Ferracane, 2013).
Amalgam has traditionally been used for direct restorations, however it is now
more common for composite resins to be used in its place. This is, in part, driven
by the patients preference for a coloured filling that matches the tooth for a more
aesthetically pleasing result. In anterior teeth, composite restorations are frequently
used for aesthetic reasons, and the failure of these is commonly due to restoration
or tooth fracture rather than secondary caries (Demarco et al., 2015). Generally,
however, secondary caries is the primary reason for composite restoration failure,
and this is due to factors relating to the material itself as well as patient-related
factors (Nedeljkovic et al., 2015). A randomised control trial showed that composite
posterior fillings have a lower survival rate than those of amalgam, although secondary
caries was the main reason for failure in both cases (Bernardo et al., 2007). Composite
fillings are generally considered safer, due to the mercury content of amalgam fillings,
however a recent Cochrane review concluded that there is no quality evidence to
support or refute this (Rasines Alcaraz et al., 2014).
1.4.2 Endodontic therapy
Endodontic therapy, more commonly termed root canal therapy, is performed where
pulpitis has become irreversible. The purpose of the treatment is to remove all the
pulp from the tooth, including the root canals, in order to eliminate bacteria and
their nutrient source and prevent disease progression. The roots are then filled and
the tooth sealed in order to prevent re-infection and maintain the tooth’s structural
integrity.
Typical endodontic preparation involves a combination of mechanical and chemi-
cal debridement (removal of infected tissue) and disinfection. Specialised tapered files
are used to mechanically remove pulp and some dentine, widening the root canals.
Following this, irrigation with sodium hypochlorite (NaClO) solution aims to dissolve
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residual necrotic tissue and kill any remaining bacteria. NaClO is widely recognised
as an effective biocide that also dissolves organic tissue (Siqueira et al., 1997, 2000;
Zehnder et al., 2002), however it has also been shown to negatively affect the me-
chanical integrity of dentine (Grigoratos et al., 2001), which may increase the risk
of tooth fracture. Pladisai et al. (2016) assessed the efficacy of both mechanical in-
strumentation (MI) and irrigation on premolars with large root canals ex vivo and
found that MI resulted in the lowest residual microbial burden of E. faecalis and that
noninvasive irrigation could not substitute MI. Progressive widening of the canals,
however, has been shown to correlate with the incidence of tooth fracture (Wilcox
et al., 1997), suggesting that a balance must be sought between effective debridement
and maintenence of structural integrity.
The most widely used root filling material is gutta percha, which may be placed
as pre-formed points or warmed in order to form a semi-solid that is mouldable to
the shape of the cavity. Zinc oxide paste is used in conjunction with gutta percha in
order to form a seal between the main filling material and the cavity walls.
Endodontic treatment may be performed in 1 or 2 stages, the 2-stage process
involving the preparation and temporary filling of the tooth followed by a subsequent
permanent filling and sealing of the tooth. The temporary filling may have antimicro-
bial properties: non-setting calcium hydroxide (Ca(OH)2) paste is a common material
used for this. The longevity of the temporary filling is dictated by the integrity of the
restorative material used to seal the tooth: often this is a glass ionomer. Prolonged
Ca(OH)2 paste treatment has been shown to alter the physical properties of dentine
(Grigoratos et al., 2001; Andreasen et al., 2002) and so, like other chemomechanical
disinfection techniques, must be used in balance with the maintenance of the tooth’s
structural integrity.
A successful root canal restoration will leave the cavity completely free of pulpal
tissue and have filled all the space within the cavity, forming a tight seal in order to
prevent bacterial leakage and re-colonisation.
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1.4.3 Vital pulp therapy
Endodontic therapy ultimately results in a non-vital tooth that is susceptible to
structural damage and microbial infection: both of which would be naturally resisted
by the reactionary mechanisms of the living dentine-pulp complex (Section 1.2.5).
Vital pulp therapy (VPT) has therefore been proposed as an alternative to endodontic
surgery (Witherspoon 2008). This treatment aims to leave some of the remaining pulp
in the tooth and encourage pulpal regeneration whilst limiting microbial activity.
Antimicrobial treatment in VPT is challenging as many biocides are cytotoxic to
the pulpal cells, including NaOCl (Essner et al., 2011). Most VPT procedures use
materials containing Ca(OH)2 or mineral trioxide aggregate (MTA).
A systematic literature review by Aguilar and Linsuwanont (2011) concluded that
VPT using Ca(OH)2 or MTA had a high reported success rate in permanent teeth
(>97 % after 3 years). Asgary et al. (2013) reported the 12-month outcome of VPT
with calcium-enriched cement (CEM) to be non-inferior to standard root canal ther-
apy and the pain-relief outcome over 7 days was reported to be better. Other studies
report worse outcomes, however, particularly in a process known as “pulp capping”,
where the coronal portion of the pulp is not removed. Barthel et al. (2000) reported a
45 % failure rate after 5 years and 80 % failure rate after 10 years with pulp capping.
A recent survey of dental practitioners in Wales found that VPT was performed
in low numbers of patients, and that the expense and poor handling properties of
MTA were cited prohibitive factors (Chin et al., 2016). This highlights the need to
develop affordable materials with desirable handling properties for this procedure.
1.4.4 Tooth extraction
In certain cases, the tooth may be removed altogether. This may be due to caries,
failed root canal treatment or periapical infection (Chestnutt et al., 2000; Richards
et al., 2005). Tooth loss is not a desirable outcome for many patients: low self-
esteem; difficulty forming relationships; restriction in diet, and reluctance to smile or
laugh in public have been reported as emotional outcomes of tooth loss (Fiske et al.,
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1998; Davis et al., 2001). Other physical problems may arise after extraction such as
infection, problems with mastication or jaw damage (Lodi et al., 2012).
1.4.5 The efficacy and survival of dental restorations and
endodontic treatments
The reasons that dental restorations fail include secondary caries, fracture of the
restoration or tooth, lost restorations and pain (Kopperud et al., 2012). This leads
to the need for re-intervention, including enlarging the cavity, performing endodontic
therapy or tooth extraction.
In England and Wales, the survival rate of dental restorations before re-intervention
has been reported to be 38-58 % over 10 years, depending on the type and size of the
restoration (Burke and Lucarotti, 2009). Restorations where root canal treatment
has been performed have a lower survival rate than those without root canal fillings,
with an estimated 10-year survival rate of 34-60 % (Lucarotti et al., 2014).
Persistence and recurrence of bacteria is recognised to be one of the foremost rea-
sons for endodontic failure. In persistent infections, bacteria may evade disinfection
and obturation when residing in isthmuses (narrow “ribbons” of pulp between canals)
and dentine tubules, as well as root canals that may have been left untreated (Tabas-
sum and Khan, 2016). The persistence of some microbial species such as E. faecalis
can cause re-infection of the cavity and further periapical infection. Eradication of
pathogens and necrotic pulp may be particularly challenging in older patients, where
root canals may be narrow and difficult to negotiate. Tooth retention, however, may
be critical for a number of reasons including the preservation of an intact dental arch
and as a retainer for prostheses (Allen and Whitworth, 2004). Poor technique may be
a cause of endodontic failure, however teeth that are well treated can still fail and the
primary cause in both cases remains to be persistent microbial infection (Siqueira,
2001).
Recurrent infection refers to a secondary infection, i.e. the contamination of the
cavity during treatment or bacterial leakage around the restoration after treatment
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(Siqueira, 2002). Endodontic failure has been linked to the quality of the restoration
of the tooth rather than the root treatment itself, as the majority of re-treated root
canals are as a result of secondary caries rather than a root canal or periapical
infection (Mannocci and Cowie, 2014).
Endodontically treated teeth are more prone to fracture due to tissue loss during
treatment and this risk is increased when roots must be re-treated due to secondary
infection (Er et al., 2011). This highlights the importance of reducing incidence of en-
dodontic failure and the need to develop non-invasive techniques for root disinfection
that do not rely on mechanical instrumentation.
1.4.6 Antimicrobial treatments
The use of systemic antibiotics is not considered to be an effective treatment for ir-
reversible pulpitis or periodontal infection (Keenan et al., 2006; Cope et al., 2014).
This is for a number of reasons, including the polymicrobial and topical nature of
dental infections. Additionally, infection as a result of caries requires mechanical
intervention to prevent further bacterial infiltration as well as treat the current in-
fection as the dental tissues have limited self-healing ability, particularly if the pulp
is compromised. It is therefore advantageous to consider the development and use of
topical antimicrobial agents to be used in conjunction with restorative materials in
order to prevent and manage dental infection.
Products used to maintain general oral hygiene include toothpastes and mouth-
washes. These are designed to prevent and inhibit plaque formation, alongside
mechanical plaque removal by brushing and flossing. Chlorhexidine, triclosan and
sodium lauryl sulphate are all examples of broad-spectrum antimicrobial agents used
in these products (Marsh, 2010). One study found that mouthwashes containing
triclosan had greater antimicrobial effect against S. mutans, Escherichia coli and
Candida albicans when compared to mouthwashes containing chlorhexidine gluconate
and potassium nitrate formulations (Prasanth and Capoor, 2013).
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Antimicrobials are also used in management of disease and during treatment pro-
cedures. A typical chemomechanical preparation for endodontic treatment is the
irrigation of the prepared root canal with NaOCl, followed by temporary filling with
Ca(OH)2 paste. Ca(OH)2 has been shown to have good antimicrobial effects in vitro,
including the ability to eradicate E. faecalis from root canals that were incubated
with the baterium for 3 weeks, treated with Ca(OH)2 paste for 7 days, and the
resulting dentine broken down into chips, which were incubated and observed for
bacterial growth (Han et al., 2001). Its effect against multi-species biofilms, however,
is disputed (Mohammadi et al., 2012). An in vivo study looked at the microbial
presence in teeth following a typical root canal preparation and found that, although
significantly lowered, a bacterial presence still persisted in the root canals, suggesting
that there is still a need for more effective treatment (Roˆc¸as and Siqueira, 2011).
1.5 Liposomal drug delivery
Liposomes are artificially produced, self-assembling spherical vesicles comprising of
one or more phospholipid bilayers surrounding an aqueous core. Phospholipids have
a hydrophilic head group and two hydrophobic tails, making them poorly soluble
in water unless they self-assemble to form a bilayer. The perimeter of the bilayer
has an energy associated with it where the hydrophobic tails are exposed to water.
This energy can be minimised if the bilayer bends and closes to form a vesicle, and
it is this that drives the self-assembly of phospholipids into liposomes (see Figure
1.4). These vesicles, initially named ‘bangosomes’, were first described in 1965, when
it was observed that phospholipids spontaneously formed large, multilamellar vesi-
cles in water (Bangham et al., 1965). Liposomes composed of naturally occurring
phospholipids were used as models of the cell membrane due to their similarity in
structure (Papahadjopoulos and Watkins, 1967), and it is this structural similarity
and biocompatibility that makes them ideal for use in the biomedical field. Addition-
ally, their ampiphilic nature means they can be used to encapsulate both hydrophilic
and hydrophobic drugs for therapeutic delivery.
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Figure 1.4: Schematic illustrating phospholipid self assembly involved in
liposome formation. A phospholipid molecule with hydrophilic and hydrophobic
regions (A) will self-assemble as a bilayer (B) under certain conditions. A liposome
(C) is formed when the bilayer folds and closes upon itself to form a spherical vesicle.
Schematic is not to scale.
The first commercially available liposomes, AmBisome R©, contain the antifungal
drug amphotericin B and continue to be used to treat serious fungal infections (Adler-
Moore, 1993). Currently, 15 liposomal formulations are in clinical use (Table 1.1), 7
of which are used in cancer therapy (Bulbake et al., 2017). There are currently no
liposomal formulations used in treating bacterial infections, and particularly not for
oral infections.
The physical characteristics of liposomes, such as size, charge and lamellarity, can
be adapted for their intended application. These characteristics are dependent on the
lipid composition and the method used for preparation, as well as the characteristics
of the compound they are used to encapsulate.
1.5.1 Liposome composition
Phospholipids used for liposome preparation are usually naturally derived, biodegrad-
able and have a molecular shape that will favourably form bilayers in aqueous envi-
ronments (in contrast to phospholipids that form micellar structures). They typically
consist of a polar head group linked to two fatty acid chains by a glycerol molecule.
Changing the headgroup of the phospholipid can change the overall charge of the
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Table 1.1: Summary of liposomal formulations approved for clinical use.
HSPC (hydrogenated soy phosphatidylcholine); PEG (polyethylene glycol); DSPE (distearoyl-sn-
glycero-phosphoethanolamine); DSPC (distearoylphosphatidylcholine); DOPC (dioleoylphosphatidyl-
choline); DPPG (dipalmitoylphosphatidylglycerol); EPC (egg phosphatidylcholine); DOPS (di-
oleoylphosphatidylserine); POPC (palmitoyloleoylphosphatidylcholine); SM (sphingomyelin); MPEG
(methoxy polyethylene glycol); DMPC (dimyristoyl phosphatidylcholine); DMPG (dimyristoyl phos-
phatidylglycerol); DSPG (distearoylphosphatidylglycerol); DEPC (dierucoylphosphatidylcholine);
DOPE (dioleoly-sn-glycero-phophoethanolamine). Table adapted from (Bulbake et al., 2017)
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liposome. Liposomes that are highly cationic or anionic will repel each other in an
aqueous suspension and therefore are more stable as they are less likely to aggregate.
Neutral or cationic liposomes, however, are more stable than anionic liposomes in
vivo, as they are less likely to bind to blood proteins and therefore stay in circulation
longer (Herna´ndez-Caselles et al., 1993). Liposomes containing phosphatidylserine
have been observed to induce apoptosis in some cell types as they are thought to
mimic the serine-rich cell membrane of an apoptotic cell (Hosseini et al., 2015).
Many commercial liposome formulations contain cholesterol, as it is used to op-
timise the stability and release characteristics of liposomes. Demel and De Kruyff
(1976) observed that cholesterol increases the packing density of phospholipid molecules
in the bilayer and therefore reduces the permeability of the membrane, which would
allow for slower drug release. It can also improve the physical stability of the li-
posome and its resistance to shear stress because the membrane has higher rigidity
when cholesterol is added (Liu et al., 2000). Aramaki et al. (2016) found that choles-
terol increased the charge of cationic liposomes, therefore reducing the concentration
of cytotoxic cationic surfactant required to obtain the same charge. Cholesterol ad-
dition may, however, reduce the encapsulation efficiency of liposomes, as was found
by Mohammed et al. (2004) when incorporating ibuprofen into phosphatidylcholine
liposomes.
1.5.2 Liposome preparation methods
Several methods have been developed for the production of liposomes, a summary
of which are shown in Table 1.2. Different preparation techniques result in different
liposome sizes, ranging from tens of nanometres to tens of microns in diameter. In
addition, liposomes may have different lamellarity, as summarised in Figure 1.5.
Most liposome preparation methods produce multilamellar and/or large liposome
sizes, and so post-production modifications such as extrusion, homogenisation or
sonication are employed to reduce liposome size and polydispersity, usually resulting
in dispersions of small unilamellar vesicles (SUVs) for clinical use. Liposomes may
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Figure 1.5: Schematic showing liposome classification by size and lamel-
larity. Phospholipid bilayers will form spherical vesicles that may be classed as gi-
ant, large, or small unilamellar vesicles. Vesicles containing more than 1 membrane,
or lamella, are classed as multilamellar vesicles (with many concentric lamellae) or
multivesicular vesicles (with mulitple vesicles contained in the same large vesicle).
Schematic is not to scale.
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Table 1.2: Summary of liposome preparation methods.
GUV (giant unilamellar vesicle); MLV (multilamellar vesivle); LUV (large unilamellar vesicle);
SUV (small unilamellar vesicle). Adapted from (Patil and Jadhav, 2014)
also be lyophilised for long-term storage, with some formulation modifications (Chen
et al., 2010).
Multilamellar vesicles (MLVs) and multivesicular vesicles (MVVs) have a larger
lipidic surface area and have a propensity to carry a higher concentration of drugs.
Maestrelli et al. (2006) prepared MLVs, LUVs and SUVs using various methods and
measured their encapsulation efficiency of the anti-inflammatroy drug ketoprofen.
They found that MLVs had the highest encapsulation efficiency, followed by LUVs
and then SUVs. Berger et al. (2001) extruded MLVs containing the hydrophilic
dye calcein through different pore sizes and found that the encapsulation efficiency
correlated with particle size. A larger particle size, however, makes them easier for
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the body’s mononuclear phagocyte system (MPS) to detect and eradicate (Malam
et al., 2009). SUVs are therefore preferred in a clinical setting, as they will stay in
circulation longer and are more likely to reach their therapeutic target, if they are
administered systemically (Gubernator, 2011).
1.5.3 Liposomes for antimicrobial drug delivery
As previously discussed, liposomes are often employed in the delivery of therapeutics,
as they can improve the solubility of hydrophobic drugs and are highly biocompatible.
Liposomes have not yet been utilised for the control of dental infections, however some
research has been done on this possibility.
Cationic and anionic liposomes have been shown to be adsorbed into single and
2-species biofilms in vitro and can effectively deliver triclosan to inhibit growth of
S. sanguis but not S. salivarius (Robinson et al., 2001b). Anionic liposomes can be
adsorbed into hydroxyapatite (a model for dental enamel), although they also in-
teract with salivary components, which reduces their efficacy (Nguyen et al., 2011).
Recent work within the Cardiff University Mineralised Tissue Group has also found
that neutral triclosan loaded liposomes are more effective than free drug against S.
anginosus using an ex vivo model of rat pulpal infection (Roberts et al., 2013a,b).
Additionally, liposomes could be incorporated into glass ionomer cements/MTA for
the successful delivery of antimicrobials without compromising mechanical and ma-
terial properties. This was not the case for composite resins, which do not absorb
water, hence did not release triclosan. Furthermore, light activation of materials was
found to degrade triclosan, rendering it inactive against bacteria (unpublished data).
This work shows promise for triclosan liposomes to be used in a non light-activated
composite system for dental antimicrobial delivery. In particular, it suggests that a
material with a high aqueous content would best allow liposome release, such as a
hydrogel.
CHAPTER 1. GENERAL INTRODUCTION 33
1.6 Hydrogels for drug delivery
1.6.1 Hydrogels
Hydrogels can be described as 3-dimensional (3D) structures of hydrophilic polymers
that retain a large amount of water. Despite their significant aqueous component,
they possess a solid-like structure, provided by the supporting network of polymers.
Hydrogels are said to be chemically similar but physically distinct from gels in that
they have differing swelling properties. Hydrogels maintain their 3D structure upon
the addition of water whereas a gel will become more dilute. This is due to the level
of cross-linking between the polymers: a hydrogel inherently contains a high level of
cross-linking whereas the polymers in a gel display only weak physical entanglements
that will not inhibit their dilution in water (Gupta et al., 2002). Hydrogels may be
classified according to several features, including their source (natural or synthetic),
cross-linking bond type (ionic, hydrogen, covalent, etc.), charge (ionic, non-ionic),
polymeric composition (homopolymeric, copolymeric), or the environmental stimuli
that initiate gel formation.
1.6.2 Physical and chemical hydrogels
Cross-links that form the hydrogel structure may be in the form of physical bonds
or chemical bonds. Physical, or reversible hydrogels, include those formed by ionic,
hydrophobic or hydrogen bonding. Physical hydrogels often do not have uniform pore
sizes due to the non-homogenous nature of bond formation. Chemical hydrogels are
formed by covalent bonding and are irreversible due to the configurational changes
they undergo upon gelation. Chemically cross-linked polymers are considered to be
strong hydrogels. They generally form more solid structures, have more controllable
pore sizes and their gelation mechanism cannot be reversed. Some examples of phys-
ical and chemical hydrogels are shown in Table 1.3.
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Table 1.3: Examples of physical and chemical cross-linking in hydrogels.
Table adapted from Omidian and Park (2012)
1.6.3 Responsive hydrogels
A hydrogel may exhibit changes in structure as a response to an environmental
change, such as temperature, pH or ionic strength. Different polymers are responsive
to different environmental factors. For example, polymers containing hydrophobic
groups become less soluble and form hydrophobic cross-links at high temperatures.
Inversely, hydrocolloids such as agar, once heat-treated, will form a gel as the tem-
perature decreases due to chain aggregation of the polymers double helical structures.
Whereas non-ionic hydrogels show no sensitivity to pH changes, ionic hydrogels are
more readily influenced by pH conditions, with the type of response depending if they
are cationic or anionic. Cationic hydrogels swell in low pH conditions, leading to a
more open structure, whereas anionic hydrogels have the opposite reaction, where the
structure will swell at a higher pH value. This is as a response to ionic interractions
between the polymers and the H+ or OH− ions in the solvent (Gupta et al., 2002).
1.6.4 Hydrogels for drug delivery
Hydrogels were first described for biological use by Wichterle and Lim (1960), who
suggested the use of poly-glycolmonomethacrylate hydrogels for making contact lenses.
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Figure 1.6: Hydrogel mesh size mediates drug diffusion. A small drug to
mesh size ratio allows for rapid drug diffusion whereas diffusion slows as the ratio
approaches 1. A size ratio >1 results in drug immobilisation, unless the mesh is
enlarged through degradation, deformation or swelling of the hydrogel, which then
allows drug release. Image from Li and Mooney (2016).
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Since then, their biocompatibility and tuneable mechanical properties make them
suitable for a range of biological and biomedical uses, including as carriers for the
delivery of drugs.
Drug loading into hydrogels allows for local drug delivery, bypassing the systemic
administration route and therefore reducing the risk of off-target effects. For exam-
ple, collagen type I hydrogels containing the cytokines BMP-2 and BMP-7 are used
clinically for treatment of long bone fracture and spinal fusion (Bessa et al., 2008).
The cytokines induce bone and cartilage growth and local delivery allows for a re-
duced concentration to be administered, which may reduce undesirable side-effects,
including tumorigenesis (James et al., 2016).
Spatial and temporal control of drug release is achieved by tuning the hydrogel’s
physical properties. The size of the open spaces between polymer chains (mesh size)
relative to the drug size dictates the rate of drug diffusion, and the hydrogel response
to its environment, such as swelling, deformation or degradation, results in modifica-
tion of the mesh size and therefore the diffusion of the drug (summarised in Figure
1.6). Drug release may also be mediated through drug-polymer interactions, such as
covalent conjugation, electrostatic interactions or hydrophobic associations (Li and
Mooney, 2016).
Chemically cross-linked hydrogels generally have a more controllable mesh size
than physical hydrogels, through changing the concentration of the cross-linkers,
which allows for a greater level of control over drug release properties (Hoare and
Kohane, 2008). A limitation of this is the potential cytotoxicity of residual, un-
bound cross-linking molecules. Glutaraldehyde is often used to form carbohydrate-
based hydrogels, but is also a tissue fixative (Balakrishnan and Jayakrishnan, 2005).
Using multiple cross-linking agents may overcome this problem: for example a chi-
tosan/gelatin blend was used with a covalent cross-linker (glutaraldehyde) and an
ionic cross-linking agent with the intention of reducing the amount of toxic glu-
taraldehyde required to form the gel but retain its stability (Jatariu Cadinoiu et al.,
2011; Ciobanu et al., 2014).
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1.6.4.1 Injectable hydrogels for drug delivery
Local drug delivery can be achieved by implanting a pre-formed hydrogel to the
delivery site, however in some cases this may require surgery to access the site. Ad-
ditionally, the gel would have to be pre-formed to fit the desired spacial parameters.
Injectable hydrogels have gained interest in the biomedical field as they offer an al-
ternative method of hydrogel delivery that eliminates the need for invasive surgery
and allows the gel to take up the shape of the cavity it is injected into.
Injectable hydrogels are so-called because of the relatively low viscosity of the
initial material, usually in the form of a polymer/drug solution. This can then be
injected into the body and will have a physiological trigger resulting in the in situ
formation of the hydrogel. Temperature is often used as the trigger for in situ forma-
tion, for example a hydrogel based on the thermo-responsive polymer methyl cellulose
(MC) has been developed for the controlled delivery of Neurotrophin-3 to the injured
spinal cord (Gupta et al., 2006; Elliott Donaghue et al., 2014).
1.6.4.2 Hydrogels for liposomal drug delivery
Due to the aqueous environment within the polymer network of a hydrogel, there
is a limited capacity to carry hydrophobic drugs. As such, composite gel systems
have been developed that include loading hydrophobic drugs into aqueous colloidal
suspensions, such as micelles or liposomes, for hydrogel incorporation (Hoare and
Kohane, 2008; McKenzie et al., 2015). There are also examples of hydrophilic drugs
being encapsulated in liposomes before addition to the hydrogel in order to allow for
more controlled drug release. Ingebrigtsen et al. (2017) loaded the antibiotic chlo-
ramphenicol into liposomes for incorporation into a chitosan hydrogel for topical,
dermal delivery and its in vitro antimicrobial activity was greater than that of chlo-
ramphenicol solutions alone. Mao et al. (2016) used an injectable hydrogel to deliver
liposomes containing the hydrophobic chemotherapeutic drug paclitaxel in a mouse
model of pancreatic cancer. They found that intratumoural injection of the hydrogel
resulted in a high local paclitaxel concentration, sustained and stable drug release,
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extend drug retention inside the tumour, and low toxicity to normal tissues.
A composite liposomal/hydrogel system could potentially combine the advantages
of liposomal drug encapsulation (Section 1.5) and hydrogel drug delivery to develop
a medicament for effective, local antimicrobial delivery to sites of potential dental
infection.
1.7 Aims and objectives
The primary aim of this thesis is to develop a material with antimicrobial properties
that has a use in dental restorations in order to control pulpitis and root canal
infection. It will:
• Determine the suitability of liposomes to encapsulate and release the antimi-
crobial triclosan;
• Investigate the ability of polymer hydrogels to carry and deliver liposomes;
– Hydrogels will be assessed for their suitability as dental restoration ma-
terials that can carry liposomes and deliver their contents. Rheological
studies will assess the handling properties of the hydrogel and any effect
that liposome incorporation will have on these properties;
• Investigate the effects of antimicrobial agents released on common pathogenic
bacteria implicated in the development of pulpitis and root canal disease;
– The effect of liposomal triclosan released from the gel will be measured
using in vitro assays and a root canal infection model.
Chapter 2
Characterisation of Bacterial
Isolates and Assessment of the
Antimicrobial Efficacy of Triclosan
2.1 Introduction
Microbial infections following endodontic surgery are difficult to treat and, if allowed
to progress, can lead to irreversible tissue damage and systemic infection. Studies that
have isolated bacteria from root canals following endodontic failure have found that
failure is not associated with a single species alone, however some species are more
commonly isolated than others. Gomes et al. (2004) found a significant association
between teeth that had previously undergone endodontic treatment and the presence
of Enterococcus and Streptococcus species in root canal isolates.
Streptococcus anginosus, alongside Streptococcus constelatus and Streptococcus
mutans, are part of the Streptococcus anginosus group (SAG) of bacteria, which
have clinical similarities and are implicated in early colonisation and secondary infec-
tion of the dental pulp (Lamothe, 1990; Jenkinson and Demuth, 1997). Enterocoocus
faecalis is commonly isolated from filled root canals, however it is not often found in
advancing carious lesions and its mode of infiltration into the root canal system is
unknown (Zehnder and Guggenheim, 2009).
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Despite the predominance of E. faecalis, root infections are generally polymicro-
bial, and therefore antimicrobial selection must take this into account. Triclosan
is a broad-spectrum antimicrobial agent that is used in a variety of dental hygiene
products, including mouthwash and toothpaste. Its mode of action is concentration-
dependent, with high concentrations being bactericidal and lower concentrations be-
ing bacteriostatic. Its bacteriostatic effect comes from inhibition of fatty acid pro-
duction at the enoyl-acyl carrier protein reductase (FabI) step (Heath et al., 1999).
As a biocide, it has multiple cytoplasmic and membrane targets (Russell, 2004).
A recent Cochrane review showed that the use of triclosan toothpaste reduced
plaque, gingivitis, bleeding gums and caries in patients when the triclosan was deliv-
ered in combination with a copolymer to reduce the dilution of the drug with mouth
rinsing or saliva (Riley and Lamont, 2013). Triclosan is not currently used for the
treatment pulpitis or endodontic infection, however there is some evidence to sug-
gest its potential efficacy. Nudera et al. (2007a) showed triclosan efficacy against
5 endodontic pathogens, including E. faecalis in vitro and Roberts et al. (2013c)
demonstrated triclosan efficacy against S. anginosus in an ex vivo rat model of pul-
pal infection.
This chapter characterises strains of E. faecalis and S. anginosus for modelling
endodontic infection. It also assesses the antimicrobial efficacy of triclosan against
these bacteria and considers its use as a model antimicrobial for further incorporation
into a dental filling material.
2.2 Materials and methods
2.2.1 Preparation of bacterial stocks and growing conditions
Clinical isolates E. faecalis RB17 (origin: gastrointestinal tract) and S. anginosus
39/2/14A (origin unknown) were selected from the culture collection of the Cardiff
School of Dentistry. Swabs were taken from samples stored at -80 ◦C and streaked
onto tryptone soya agar (TSA) plates, which were then incubated at 37 ◦C in 5 %
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CO2 for 18 h.
For growth inhibition experiments, overnight broth cultures were prepared: brain
heart infusion (BHI) broth was inoculated with a single colony of bacteria taken from
a TSA plate and this was incubated at 37 ◦C in 5 % CO2 for 18 h prior to further
use. All growth inhibition experiments were performed on 3 separate occasions with
a fresh overnight broth culture.
2.2.2 Confirmation of bacterial species
2.2.2.1 Gram stain
Bacteria were Gram-stained in order to assess their morphology and check for con-
tamination. Using a sterile wire loop, a swab was taken from a TSA plate culture
and smeared on a glass slide with a drop of sterile water. The slide was air-dried
and then heat-fixed over a bunsen flame. The slide was then flushed with crystal
violet solution for 60 s, rinsed with tap water and then flushed with Lugoli’s iodine
solution for 60 s. Acetone was used to rinse the slide, before Carbol fuchsin solution
was applied for 60 s. The slide was then rinsed with tap water and air-dried before
it was viewed using oil-immersion light microscopy.
2.2.2.2 Genetic sequencing
DNA was extracted from the bacteria and the 16S ribosomal RNA (rRNA) region
was sequenced to confirm correct species identification. E. faecalis and S. anginosus
were collected from an overnight culture grown on TSA. DNA was extracted using a
QIAamp DNA Mini Kit (Qiagen, Manchester, UK) according to the manufacturer’s
protocol (see Appendix A). DNA samples were then amplified at the 16S rRNA
region using forward and reverse primers D88 and E94 and this DNA region was se-
quenced (amplification and sequencing was performed by Cardiff University Central
Biotechnology Services). The resulting sequences were entered into the Basic Local
Alignment Search Tool (BLAST) to assess how similar the sequences were to known
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bacterial strains (National Center for Biotechnology Information, U.S. National Li-
brary of Medicine, Bethesda MD). A match of 95 % or above to the correct bacterial
species was considered adequate.
2.2.3 Bacterial growth with triclosan
2.2.3.1 Preparation of triclosan solutions
Triclosan was dissolved in propan-2-ol (IPA) at 10 mg/mL and 6 subsequent 2-fold
dilutions were done in IPA to obtain a range of triclosan concentrations (0.3125-
20 mg/mL). BHI was then added dropwise to obtain a final IPA concentration of
1 % (v/v) and final triclosan concentrations of 3.125-200µg/mL. Control solutions
contained only 1 % (v/v) IPA in BHI.
2.2.3.2 Growth of bacteria with triclosan and determination of the min-
imum inhibitory concentration (MIC)
Triclosan solutions (0-200 µg/mL) in 1 % IPA (v/v) were pipetted into a 96-well plate
(100µL/well). Overnight broth cultures of E. faecalis and S. anginosus were diluted
in BHI to obtain an optical density of 0.08-0.1 at 600 nm. Two further 10-fold dilu-
tions in BHI were then done and 100 µL/well of the resulting bacterial suspension was
pipetted onto the wells containing the triclosan solutions. The plate was incubated
in a plate reader (FLUOstar Omega, BMG Labtech, Ortenberg, Germany) at 37 ◦C
in 5 % CO2 for 20 h. The absorbance at 600 nm was measured every 1 h and the
plate was shaken at 40 RPM for 30 s before each measurement.
The MIC was considered to be the concentration at which no growth was observed
after 20 h.
2.2.3.3 Analysis of bacterial growth curves
Bacterial growth curves from Section 2.2.3.2 were analysed using the statistical pack-
age R (R Core Team, 2013). The growth analysis package “Grofit” was used to
analyse the growth curves produced from the obtained absorbance measurements
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Figure 2.1: Example of parameters derived from bacterial growth curves.
Example growth curve showing length of lag phase (λ), growth rate represented by
the maximum slope (µ) and maximum growth (A). Taken from (Kahm et al., 2010)
(Kahm et al., 2010). Grofit fits a model-free spline to experimental data and the
length of lag phase (λ), maximum growth rate (µ) and maximum absorbance value
(A) are derived from this fit (example shown in Figure 2.1). Where a value of λ was
less than 0 h or more than 20 h, it was assumed that there was no distinguishable
lag phase for that particular growth curve, and therefore λ and µ were excluded from
further analyses since no measurable growth had occured under these experimental
conditions.
A difference in the mean values of λ, µ and A was tested for using ANOVA with
post-hoc Tukey’s test. A P value of 0.05 or less was considered statistically significant
(“ns”=P > 0.05, *=P < 0.05, **=P < 0.01, ***=P < 0.001).
2.2.3.4 Minimum bactericidal concentration (MBC) of triclosan
To determine the MBC of triclosan, the bacterial/triclosan suspensions from the 96-
well plate of the previous experiment (Section 2.2.3.2) were used. Concentrations
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of triclosan were selected where no growth had been observed, in addition to the
two concentrations above this value. Bacteria-only and broth-only controls were also
included. The contents of the selected wells (200 µL/well) were removed and diluted
in 20 mL of BHI. This suspension was incubated for 20 h at 37 ◦C in 5 % CO2.
Where growth was visually observed (indicated by an increase in broth turbidity
compared to broth-only controls), a positive growth result was noted. Where the
broth had remained clear, these suspensions, alongside the control suspensions, were
centrifuged at 4000 ×g for 5 min and the supernatant was poured off. The remaining
pellet was resuspended in 50 µL of BHI and then spread onto a TSA plate using a
spiral plater (Don Whitley Scientific Limited, Shipley, UK). The TSA plates were
then incubated for 20 h, as previously described and inspected for growth. The MBC
was considered to be the lowest triclosan concentration at which no growth had been
observed.
2.2.3.5 Minimum biofilm eradicating concentration (MBEC) of triclosan
Overnight broth cultures of E. faecalis or S. anginosus were diluted in BHI to obtain
an optical density of 0.08-0.1 at 600 nm. Two further 10-fold dilutions were then done
and the resulting bacterial suspension was pipetted into a 96-well plate (200µL/well).
A biofilm was allowed to grow by incubating the plate at 37 ◦C in 5 % CO2 for 24
h. The wells were aspirated and washed with sterile phosphate-buffered saline (PBS,
200µL/well) to to remove unattached cells. Triclosan solutions (0-200 µg/mL, 1 %
IPA in BHI v/v, 200µL/well) were pipetted onto the remaining biofilms and the
plate was incubated for a further 24 h (37 ◦C, 5 % CO2). The triclosan solutions
were aspirated and the wells were washed with 200µL of sterile PBS before 200 µL
of BHI was then added to the wells. The absorbance at 600 nm was read on a plate
reader (FLUOstar Omega, BMG Labtech, Ortenberg, Germany) and then the plate
was incubated for a further 24 h (37 ◦C, 5 % CO2) before the absorbance was read
as before.
All absorbance values were standardised to a blank well containing 200 µL BHI
and the standardised absorbance values of the first reading were subtracted from those
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of the second reading to determine the relative growth of the bacteria. The mean
value was calculated from triplicate samples on each plate and the MBEC recorded
as the lowest concentration of triclosan that demonstrated a ≥ 80 % reduction in
absorbance compared to the control.
2.2.3.6 Growth inhibition on agar plates
Bacterial lawn plates were prepared by evenly swabbing an overnight broth culture of
E. faecalis or S. anginosus over the surface of a TSA plate using a sterile, cotton swab.
Wells were then punched into the agar using a sterile 6 mm biopsy punch. Triclosan
solutions (50µL, 0-500µg/mL in 1 % IPA) were then pipetted into the wells and the
plates were incubated at 37 ◦C in 5 % CO2 for 20 h. Growth of bacteria was believed
to be inhibited where a clear area of agar was observed around the innoculation site,
in contrast to the bacterial growth covering the rest of the plate.
2.3 Results
2.3.1 Bacterial appearance, morphology and genetic identi-
fication.
E. faecalis and S. anginosus were cultured from previously isolated bacterial stocks.
Both species grew on TSA and colonies were visible after incubation for 18 h. Figure
2.2 shows the appearance of both species on TSA. E. faecalis colonies were larger
than those of S. anginosus and had a glossy appearance.
Visual inspection of Gram-stained bacteria (Figure 2.3) confirmed that both
E. faecalis and S. anginosus were Gram-positive cocci, with no other cell morpholo-
gies identified. Cells appeared in pairs, short chains, or clusters and E. faecalis cells
were larger than those of S. anginosus.
Genetic analysis of the bacterial species used confirmed that the 16S rRNA region
of DNA matched with that of E. faecalis (D88: 97 %, E94: 99 %) and S. anginosus
(D88: 98 %, E94: 97 %), according to the BLAST database. This gave further
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Figure 2.2: Bacteria used for assessment of antimicrobial efficacy. Streak
plates of Enterococcus faecalis (A) and Streptococcus anginosus (B) show growth on
TSA after 18 h incubation at 37 ◦C in 5 % CO2.
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Figure 2.3: Gram stain of bacteria used for assessment of antimicrobial
efficacy. Gram stains of Enterococcus faecalis (A) and Streptococcus anginosus (B)
shown at 100 X magnification under oil immersion.
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confirmation that the correct species of bacteria were used in this work. The full
sequences are included in Appendix B.
2.3.2 Bacterial growth with triclosan
2.3.2.1 Growth curves for minimum inhibitory concentration (MIC) de-
termination
Bacteria were incubated for 20 h with triclosan solutions in order to assess the an-
timicrobial efficacy of triclosan against these bacterial strains. Growth curves (Figure
2.4) showed that E. faecalis and S. anginosus growth was inhibited by triclosan com-
pared to the untreated control and no growth was observed in either bacterial strain
with concentrations of 6.25µg/mL or above. Bacterial growth was not affected by
addition of 1 % IPA, which was used as the diluent for triclosan.
Table 2.1 shows the characteristic parameters derived from the growth curves us-
ing a spline fit of the experimental data. For both bacterial species, values for λ
(length of lag phase) and µ (maximum growth rate) for triclosan concentrations of
6.25µg/mL and above were excluded from analyses for reasons set out in Section
2.2.3.3. The maximum absorbance value (A) for these concentrations was signifi-
cantly lower than that of the bacteria in BHI alone (P¿0.001), indicating that the
turbidity of the suspension had not increased as much as the control and therefore
bacterial growth had been inhibited. For a triclosan concentration of 3.125µg/mL,
λ of E. faecalis was not significantly different. Values of µ and A, however, were
significantly lower than those of bacteria alone (µ:P=0.0012, A:P ¡0.001), suggesting
a partial, but not complete, inhibition of growth. A similar result is seen for S. angi-
nosus, with the exception that the reduction in A was not statistically significant
(P=0.13).
Analysis of these bacterial growth curves therefore indicated that inhibition of
both E. faecalis RB17 and S. anginosus 39/2/4A growth was achieved with triclosan
and that the minimum inhibitory concentration was 6.25µg/mL for both bacterial
strains, with partial inhibition observed with 3.125µg/mL.
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Figure 2.4: Growth of Enterococcus faecalis (top) and Streptococcus angi-
nosus (bottom) with triclosan. Bacteria were grown in BHI with triclosan in
a 96-well plate and the absorbance was measured over 20 h. Graphs show optical
density at 600 nm. Error bars show standard error of the mean of 3 independent
experiments.
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Table 2.1: Growth parameters of Enterococcus faecalis (top) and Strepto-
coccus anginosus (bottom) with triclosan.
Bacteria were grown in BHI with triclosan in a 96-well plate for 20 h. Length of lag phase
(λ), maximum growth rate (µ) and maximum absorbance value (A) of growth curves
(shown in Figure 2.4) are shown. (“SEM”= standard error of the mean, “sig.”=
significance of difference in means compared to bacteria in BHI:“ns”= P > 0.05, *=
P < 0.05, ** =P < 0.01, ***=P < 0.001)
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2.3.2.2 Minimum bactericidal concentration (MBC) of triclosan
The MBC of triclosan was determined from cultures of E. faecalis and S. anginosus
that had been incubated with 0-100 µg/mL of triclosan for 20 h, diluted to reduce the
triclosan concentration below the MIC, and then transferred to a TSA plate to allow
further growth, should any live bacteria still be present in the suspension. Growth of
E. faecalis was observed from cultures grown with 12.5 µg/mL triclosan and below,
but not with 25 µg/mL and above. Growth of S. anginosus was observed from cultures
grown with 6.25µg/mL of triclosan, but not with 12.5 µg/mL and above. Table 2.2
shows a summary of these results.
2.3.2.3 Minimum biofilm eradicating concentration (MBEC) of triclosan
Bacteria were grown as biofilms and treated with triclosan solutions to determine
the MBEC of triclosan. By the conditions set out in Section 2.2.3.5, the MBEC of
triclosan was 50 µg/mL against both bacterial species, as this was the concentration
at which a ≥80 % reduction in absorbance was observed compared to the BHI-only
control (Figure 2.5).
The results of the MIC, MBC and MBEC analyses suggested that triclosan was
bacteriostatic, but not bactericidal at concentrations between 6.25-25 µg/mL against
E. faecalis and 6.25-12.5 µg/mL for S. anginosus. Triclosan was bactericidal above
these ranges, however a triclosan concentration of 50µg/mL or more was needed to
eradicate biofilms of both these bacteria.
2.3.2.4 Zones of inhibition on bacterial lawn plates
Bacterial lawn plates that had been inoculated with triclosan solutions showed zones
of inhibition with all triclosan solutions tested, but not with negative controls. Figure
2.6 shows a representative image of the results obtained, which were similar for all 3
independent experiments. Growth of S. anginosus was visible by eye but the contrast
was low between areas of growth and areas of no growth, making it difficult to identify
clear zones of inhibition. E. faecalis growth was more evident and zones of inhibition
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Figure 2.5: Minimum biofilm eradicating concentration of triclosan. Biofilms of
E. faecalis or S. anginosus were grown and treated with triclosan solutions. Graphs show
relative absorbance over 24 h of the remaining bacterial suspensions after the triclosan
solutions had been removed. Dotted red line shows theoretical value of an 80 % reduction
in relative absorbance of the BHI-only control (error is within the line thickness). Error
bars show standard error of 3 independently performed experiments.
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Figure 2.6: Bacterial lawn plates with triclosan. TSA plates were swabbed
with cultures of Enterococcus faecalis (A) and Streptococcus anginosus (B) and in-
noculated with triclosan before incubating for 20 h. Representative images of 1 of
3 independent experiments are shown. Yellow lines are a visual aid to show areas
of observed growth inhibition. Dashed lines show areas of observed reduced growth
(E. faecalis only).
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Table 2.2: Growth of Enterococcus faecalis and Streptococcus anginosus for the de-
termination of triclosan MBC.
Bacteria were grown in BHI with triclosan in a 96-well plate for 20 h. Suspensions were
subsequently diluted to reduce triclosan concentration to sub-MIC levels and then
re-cultured on TSA plates. Table shows whether growth had occurred, with each ‘+’ or ‘-’
indicating the result of one independent experiment.
were clearly identified. Gentamycin was included as a positive control, and the zones
of inhibition observed were very clear-cut, whereas zones seen with triclosan showed
a region of lower growth, giving a ‘halo’ effect on the plate. This may be due to
the bacteriostatic effect of the drug acting on areas further away from the areas of
complete inhibition.
2.4 Discussion
The bacterial strains used for this work conformed with UK Standards for Microbi-
ology Investigations in terms of colony morphology and microscopic appearance for
both E. faecalis and S. anginosus (Public Health England, 2014) and no contamina-
tion was present in the previously isolated stocks. Additionally, 16S rRNA sequence
analyses confirmed that the species used were correctly identified.
Triclosan is a commonly used, broad-spectrum antimicrobial, which is used in
mouthrinses and toothpastes for the control of oral bacteria. Its efficacy against
E. faecalis is well documented, however there are some discrepancies in the literature
regarding the effective concentration. Some studies report the MIC against E. faecalis
to be between 1-7 µg/mL (Suller and Russell, 1999; Jones et al., 2005; Williams
and Stickler, 2008; Sun and Song, 2011), however others report a MIC of 16µg/mL
(Koburger et al., 2010; Morrissey et al., 2014) and one study found the MIC to be
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s high as 94 µg/mL (Nudera et al., 2007b). There is less evidence in the literature
on triclosan efficacy against S. anginosus, despite the prevalance of this bacterium
in oral diseases, and its importance in the advancing carious lesions that result in
pulpitis and endodontic infections. Cullinan et al. (2014) assessed the efficacy of
triclosan against dental plaque isolates of S. anginosus and found the MIC to be 125-
250µg/mL. Another study by Ledder et al. (2006), however, reported a much lower
MIC of 4µg/mL against S. anginosus isolated from a similar source. The variability
in these reported results may be due to a number of factors, including differences
in in vitro experimental conditions and potential acquired resistance of the bacteria,
particularly from clinically obtained isolates. Both Enterococcus and Streptococcus
species have the potential to develop resistance to triclosan, as they contain not only
FabI (the target of triclosan), but also FabK, an alternative enoyl-acyl carrier protein
reductase that has been shown to counter resistance to triclosan in Streptococcus
pneumoniae (Heath and Rock, 2000; Cullinan et al., 2014).
The variability in reported MICs therefore illustrates the importance of ascer-
taining the effective concentration of triclosan against the specific strains of bacteria
used in this work in order to relate the efficacy of liposomal and hydrogel formula-
tions developed in the following chapters to that of triclosan solution. The triclosan
MIC against E. faecalis obtained in this chapter (6.25µg/mL) is in agreement with
the majority of the literature and shows that triclosan has an inhibitory effect on
the tested strain of E. faecalis at relatively low concentrations, considering that the
concentration allowed in antimicrobial products is 300µg/mL (Scientific Committee
on Consumer Safety, 2010). The same MIC was seen against S. anginosus, which
suggests that triclosan is an appropriate choice of antimicrobial for the development
of a material and may have potential for inhibiting primary colonisation or preventing
secondary infection of the pulpal chamber and root canals.
The R package “grofit” was used to obtain a quantitative description of the bac-
terial growth curves and the conclusions drawn from analysis of these data agreed
with those obtained from visual inspection of the growth curves themselves. This
mode of analysis is therefore appropriate for analysing further antimicrobial efficacy
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data (Chapters 3 and 4).
The MBC of triclosan was 4-times higher than the MIC against E. faecalis. Other
studies have reported an MBC as 2-fold greater (Morrissey et al., 2014) or equal to
the MBC (Nudera et al., 2007b; Koburger et al., 2010). For S. anginosus, the MBC
was 2-fold higher than the MIC: a result which was also observed by Ledder et al.
(2006). These data, along with results found in the literature suggest that triclosan
is bacteriostatic against the two strains tested, but is also an effective bactericide
at relatively low concentrations, which is promising for its application in preventing
recurrence of infection.
For determining the MBC, it was assumed that residual triclosan activity in the
samples would be halted by the dilution to sub-MIC levels and subsequent centrifu-
gation and resuspension of bacteria. The standards for antimicrobial testing suggest
a neutraliser should be used to inhibit any residual antimicrobial activity, in order to
obtain the MBC (McDonnell et al., 1998; British Standards Institution, 2005), there-
fore the true MBC of triclosan for these bacterial strains may be higher than those
reported here. This work, however, serves as an estimate and the efficacy is further
assessed in a more clinically relavent setting for the intended application (Chapter
5).
Oral bacteria predominantly reside as biofilms rather than in the planktonic state
(Do et al., 2013) and therefore the MBEC of triclosan was assessed in order to get an
estimate of the concentration required to eradicate these bacteria in a biofilm. It was
observed that the MBEC was almost 10-fold higher than the MIC for single species
biofilms of both bacteria (50 µg/mL), which demonstrates the additional challenges
faced in erradicating bacteria in this form.
The observation of zones of inhibition on bacterial lawn plates is a commonly
used method for testing antimicrobial efficacy of materials. This method was there-
fore tested with triclosan solutions against E. faecalis and S. anginosus in order to
observe whether this method would be suitable for testing triclosan liposomes and
liposome-loaded hydrogels, which are discussed in subsequent chapters. Zones of in-
hibition were clearly observed on E. faecalis lawn plates at all concentrations that
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had previously shown growth inhibition of planktonic bacteria. This was also true
with S. anginosus however the zones of inhibition were not as distinguishable from
the background bacterial growth. This may be due to the smaller colony size of
S. anginosus and therefore the growth on the agar surface appears less opaque than
that of E. faecalis. This may be improved by selecting a different culture medium or
by different imaging methods, such as scanning and the use of image analysis software
(e.g. ImageJ). The zones of lower growth (‘halos’) observed may show areas where
triclosan is present at concentrations that slow the growth, identified by a longer lag
phase, lower rate of growth and lower maximum absorbance in the previously shown
growth curves.
These results suggest that this method may be suitable for testing the materials,
however care must be taken when observing plates of S. anginosus.
2.5 Conclusions
From these data, it is concluded that triclosan is an effective antimicrobial against two
strains of oral bacteria known to be implicated in pulpitis and secondary endodontic
infections. These results serve as a basis for the further antimicrobial testing of
liposomes containing triclosan and liposome-loaded hydrogels, for their suitability to
treat endodontic infection.
Chapter 3
Preparation and Characterisation
of Liposomes for Antimicrobial
Drug Delivery
3.1 Introduction
The use of broad-spectrum antimicrobials in oral health care can help prevent the
attachment, proliferation and migration of pathogenic oral bacteria, as has been seen
in the case of triclosan in Chapter 2. Major challenges lie in the delivery of these
antimicrobials to the correct area, at a clinically relevant concentration and for a
suitable period of time. Drugs with poor water solubility are particularly difficult to
adminster, as they require dissolution in organic solvents, which may have undesirable
cytotoxic effects if used for prolonged periods of time. Liposomal delivery systems
offer a solution to poor drug solubility, as the amphiphilic nature of liposomes allows
for the loading of both hydrophilic and hydrophobic drugs at clinically significant
concentrations.
Liposomes are nanometre-sized, artificially-produced, spherical vesicles compris-
ing of one or more phospholipid bilayer membranes and an aqueous core (Sessa and
Weissmann, 1968). Their ability to encapsulate a variety of molecules and their
structural resemblance to the cell membranes makes them ideal candidates for drug
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delivery systems. Liposomes are composed of natural lipids and are biodegradable, of-
fering good biocompatibility. Additionally, the liposomal membrane may be modified
to facilitate controlled release of therapeutics over time, as well as targeted delivery.
Drug structure, concentration and hydrophobicity can affect the formation and
conformation of the liposomes. Larger, multilamellar vesicles (MLVs) may offer a
higher drug-loading efficiency, however small unilamellar vesicles (SUVs) are less
likely to be identified by the body’s immune system and eradicated, therefore allowing
for more effective drug delivery. Both MLVs and SUVs were prepared for this work,
in order to compare the drug loading and overall efficacy of the two vesicle types.
Phosphatidylcholine (PC), shown in Figure 3.1, is a commonly used liposomal
phospholipid. It is a major component of biological membranes and is therefore
readily extracted and highly biocompatible. The head group of PC is cationic, how-
ever the overall charge is neutralised by the phosphate molecule at the phosphatidyl
moiety.
Liposomes containing the antimicrobial drug triclosan have previously been stud-
ied for antimicrobial delivery. Various formulations were observed to have an antimi-
crobial effect in vitro against Staphylococcus epidermidis biofilms, which are prevalent
in catheter and implant infections (Jones et al., 1994), as well as biofilms of Strep-
tococcus sanguis, which is found in dental plaque and can also colonise heart valves,
causing endocarditis (Robinson et al., 2001a). El-Zawawy et al. (2015) found that
triclosan liposomes had efficacy against systemic Toxoplasmosis gondii infection in
an in vivo murine model and that the triclosan liposomes were superior to triclosan
in solutions. Liposomal encapsulation of triclosan has not, however, been considered
for control of endodontic infections and there is a lack of systematic studies looking
at the effect of drug loading concentration on liposome characteristics and efficacy.
This chapter describes the development of a liposomal delivery system for the
hydrophobic antimicrobial triclosan, including the optimisation of drug loading con-
centration and preparation methodology, and how this relates to antimicrobial efficacy
against common endodontic pathogens.
CHAPTER 3. PREPARATION OF ANTIMICROBIAL LIPOSOMES 60
Figure 3.1: Lipids used for liposome preparation. The structure of phosphatidyl-
choline (left) and cholesterol (right), used for liposome preparation.
3.2 Materials and methods
3.2.1 Liposome preparation
Liposomes were prepared with egg yolk phosphatidylcholine (PC) and cholesterol
(C), shown in Figure 3.1. PC and C were weighed and combined in a weight ratio of
7:1 respectively and placed in a 50 mL round-bottomed flask. Triclosan (0-1 mg/mL)
was dissolved in chloroform and 5 mL of this solution was added to the flask with the
lipids. The suspension was then vortexed until the lipids had dissolved. Chloroform
was removed using rotary evaporation to leave a lipid film on the base of the flask.
Distilled H2O was added and the flask was vortexed to form a liposome suspension
with lipid concentration of 1 mg/mL and triclosan concentrations of 0-500µg/mL.
At this stage, liposomes were assumed to be, and referred to as, multilameller vesicles
(MLVs). Half of the suspension was retained for analysis and half was extruded 5
times under nitrogen pressure (8 bar maximum) using a Lipex extruder (Northern
Lipids Inc., British Columbia, Canada) vertically through a 200 nm polycarbonate
membrane (Whatman, UK) followed by further extrusion 10 times through a 100
nm polycarbonate membrane. These samples were assumed to be, and referred to
as, small unilamellar vesicles (SUVs). All suspensions were stored at 4 ◦C prior to
analysis. Table 3.1 shows a summary of the liposome formulations produced.
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Table 3.1: Summary of liposome formulations prepared for characterisation.
3.2.2 Size and polydispersity
The hydrodynamic diameter and polydispersity index of the liposome formulations
was measured using dynamic light-scattering (DLS) in a Brookhaven Zeta Plus par-
ticle analyser (Brookhaven Instruments Corporation Holtsville, NY). Liposomes were
diluted approximately 1:9 in H2O and placed in a quarz cuvette (2 mL). A minimum
of 3 measurements (2 min each) was taken for each sample and the mean hydrody-
namic diameter and polydispersity index (PDI) were obtained.
3.2.2.1 Heat stability of liposomes
To ensure that the liposomes were able to withstand the high temperatures required
for incorporation into a methylcellulose hydrogel (see Chapter 4), samples were placed
in a waterbath set to 80 ◦C for 10 min, removed, and allowed to cool before the size
was measured, as previously described.
3.2.2.2 Data analysis
Least-squares regression analysis was used to determine the coeffficient of determi-
nation (R2) of the liposome size and PDI. A difference in the mean hydrodynamic
diameter was tested for using ANOVA with post-hoc Tukey’s test. A P value of
0.05 or less was considered statistically significant (“ns”=P > 0.05, *=P <0.05,
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**=P < 0.01, ***=P < 0.001).
3.2.3 Zeta potential
The zeta potential of liposomes was measured using a Malvern Nano-Zs Zeta Sizer
(Malvern Instruments, Malvern, UK). Liposomes were diluted approximately 1:9 in
H2O and placed in a folded capillary zeta cell (1 mL). The zeta potential for each
sample was taken as the mean of 3 measurements.
3.2.4 Phospholipid concentration
The phospholipid concentration of liposome suspensions was measured in order to
ascertain whether there was a loss of materials throughout the preparation process.
A phospholipid assay kit (Sigma Aldrich, Gillingham, UK) was used to quantify
phospholipids. This assay enzymatically releases choline from samples, which is then
quantified colourimetrically using choline oxidase and a H2O2 specific dye.
PC standard solution was diluted in TritonTM X-100 (0.5 % v/v) to obtain con-
centrations of 0, 25, 50, 100 and 200 µmol/L. The liposome suspensions were diluted
1:7 in TritonTM X-100 (0.5 % v/v). Standards or liposome samples were then pipet-
ted in duplicate into a 96 well plate (20µL/well) and 80 µL of the assay reaction
mix, prepared according to the manufacturer’s protocol (Appendix C), was added to
each well. The plate was incubated in darkness at ambient temperature for 30 min
before the absorbance was measured at 570 nm on a plate reader (FLUOstar Omega,
BMG Labtech, Ortenberg, Germany). The sample phospholipid concentration was
determined from comparison of the sample absorbance values to the standard curve
produced from standard PC solution absorbance values. The concentration in µmol/L
was converted to mg/mL, assuming that the PC used for liposome preparation had
a molecular weight of 768 g/mol.
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3.2.5 Triclosan concentration
3.2.5.1 HPLC apparatus
The triclosan concentration of liposome suspensions was measured using high-performance
liquid chromatography (HPLC). The HPLC system comprised of an Agilent 1200
G1379B degasser, HP Agilent 1100 HPLC G1310A Isocratic Pump, HP Agilent 1100
G1313A Autosampler, and HP Agilent G1314A variable wavelength detector (VWD).
HPLC was performed using Agilent Eclipse Plus C18 column (4.6 mm × 100
mm, 3.5 µm). A 10 µL injection of sample or calibration standard was analysed by
isocratic elution using mixed acetonitrile and H2O (7:3) as HPLC mobile phase (flow
rate 1 mL/min). The analytical wavelength was set at 285 nm. Data collection and
analysis were performed using Agilent Chemstation.
3.2.5.2 Determination of optimum analytical wavelength for triclosan
Triclosan was dissolved in methanol at a concentration of 1 mg/mL. This was pipetted
into a 96-well plate (90 µL/well) and the absorbance was measured at wavelengths
220-500 nm (1 nm intervals) in a FLUOStar Optima plate reader (BMG labtech,
Ortenberg, Germany). The absorbance values were blank corrected by subtracting
the measurement obtained from an empty well at each wavelength. An optimum
analytical wavelength was chosen based on the presence of a peak in absorbance at
that particular wavelength.
3.2.5.3 HPLC calibration standard solutions of triclosan
Calibration standard solutions of triclosan were prepared in methanol at concentra-
tions of 0, 1, 2, 5, 10, 20, 30, 40, 50, 75 and 100µg/mL. HPLC was performed as
described above and the resulting peak areas for triclosan (y) were plotted against the
respective triclosan concentration (x). Least-squares regression analysis was used to
determine the slope and coeffficient of determination (R2) of the data. The regression
line equation was used to determine the triclosan concentration of liposome samples
with unknown triclosan concentration.
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3.2.5.4 Liposome samples
Liposome samples were diluted in methanol at a v/v ratio of 1:4 prior to HPLC
analysis, as described above. The peak area of the triclosan was compared to those
of the calibration standards in order to determine the triclosan concentration of the
samples.
3.2.6 Triclosan:phospholipid ratio of liposome formulations
The drug:lipid ratio of liposome formulations was calculated from the triclosan con-
centration and phospholipid concentration values obtained from Sections 3.2.4 and
3.2.5. The ratio was determined by the formula:
Triclosan:phospholipid ratio (w/w) =
Triclosan concentration (µg/mL)
Phospholipid concentration (µg/mL)
.
3.2.7 Bacterial growth with triclosan liposomes
The antimicrobial efficacy of the liposomes was assessed using a growth inhibition
experiment, as previously described in Chapter 2, Section 2.2.3.
Liposome suspensions were pipetted into a 96-well plate (20µL/well). Overnight
broth cultures of E. faecalis or S. anginosus, prepared as previously described (Sec-
tion 2.2.1), were diluted in BHI to obtain an optical density of 0.08-0.1 at 600 nm.
Two further 10-fold dilutions in BHI were then prepared and the resulting bacterial
suspension pipetted onto the wells containing liposomes (180 µL/well). The plate was
incubated in a plate reader (FLUOstar Omega, BMG Labtech, Ortenberg, Germany)
at 37 ◦C in 5 % CO2 for 20 h. The absorbance at 600 nm was measured every 1 h
and the plate was shaken at 40 RPM for 30 s before each measurement.
The resulting bacterial growth curves were analysed as previously described in
Chapter 2, Section 2.2.3.3.
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Figure 3.2: Lipid films formed during liposome preparation. Phospholipids
with or without triclosan were dissolved in chloroform, which was then removed using
rotary evaporation to form a lipid film on the bottom of the 50 mL round bottomed
flasks. The formulation containing triclosan (T300, right) is more transparent than
the control with no triclosan (T0, left).
3.3 Results
3.3.1 Liposome preparation
Liposomes were prepared with and without triclosan and qualitative differences were
observed between the different formulations during the preparation process. Upon
the removal of chloroform using rotary evaporation, the remaining lipid film was
checked for any inconsistencies before it was resuspended in H2O. Here it was observed
that the lipid films with triclosan showed greater transparency than those that did
not contain triclosan (an example is shown in Figure 3.2). In addition, the lipid
film containing triclosan showed higher adhesion to the glass surface of the flask
and it was not possible to remove all visible lipid residue from the side of the flask
upon resuspension in H2O. It was for this reason that the phospholipid and triclosan
concentration of the different formulations was quantified, in order to ascertain how
much of the original material was being lost at this stage in the production process.
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3.3.2 Liposome size and polydispersity
The size of the liposomes was measured without extrusion (MLVs) and after extrusion
through a 100 nm membrane (SUVs). It was also measured as a function of the
triclosan concentration added to each formulation (0-500 µg/mL). The size of the
liposomes is shown in Figure 3.3 and the PDI is shown in Table 3.2.
Liposome MLVs varied in size, with the hydrodynamic diameter ranging from
approximately 200 to 1000 nm. After the liposomes had been extruded to SUVs, all
samples had a hydrodynamic diameter of around 100 nm, with a narrow standard
error (<10 nm).
There was a negative correlation observed between the concentration of triclosan
added to the formulation and the hydrodynamic diameter of the MLVs up to 300 µg/mL
triclosan(R2=0.99). There was no significant difference between the size of T300 and
T500 liposomes. There was also a weak negative correlation between the added
triclosan concentration and the PDI of the liposome samples (R2=0.71). This sug-
gested that MLVs prepared with triclosan were smaller and less polydisperse than
those without triclosan.
There was no change in the size of SUVs regardless of triclosan concentration,
however there was a positive correlation between the added triclosan concentration
and the PDI (R2=0.72). There was also a convergence of PDI values seen between
MLVs and SUVs, with a large difference observed in liposomes with no triclosan,
and no difference seen between the MLVs and SUVs of samples with 500µg/mL of
triclosan added (T500). Therefore, liposomes prepared with 300 or 500 µg/mL of
triclosan have a similar size and PDI, regardless of whether or not they are extruded
after preparation, compared to control liposomes containing no triclosan.
3.3.2.1 Heat stability of liposomes
The stability of the liposomes was tested in order to ensure that the preparation
methods of methylcellulose solutions would not have an adverse affect on the lipo-
somes. Liposomes showed no significant change in size after heating to 80 ◦C for 10
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Figure 3.3: Hydrodynamic diameter of PC:C liposomes prepared with tri-
closan. Liposome MLVs and SUVs were prepared with various concentrations of
triclosan (0-500µg/mL). The graph shows the hydrodynamic diameter of each for-
mulation, measured using DLS. Bars with error bars show mean with standard error
of 3 independently prepared samples. Where error bars are not visible, they are
contained within the bar.
Table 3.2: Polydispersity index of liposome MLVs and SUVs prepared with
triclosan.
Values are mean value of 3 independently prepared samples ± standard error.
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Figure 3.4: Hydrodynamic diameter of liposomes before and after heat-
ing. Liposome MLVs and SUVs, containing various concentrations of triclosan, were
heated to 80 ◦C for 10 minutes. The graph shows hydrodynamic diameter of each
formulation before and after heating, measured using DLS. Error bars show standard
error of 3 independently prepared samples.
minutes, as shown in Figure 3.4.
3.3.3 Liposome zeta potential
Table 3.3 shows the zeta potential of liposome formulations. The zeta potential was
negative, but absolute values are low, suggesting only a weakly negative charge is
present. This may suggest that particles are more likely to aggregate over time.
There was no significant difference between samples loaded with different triclosan
concentrations, suggesting that the changes in hydrodynamic diameter were due to
a difference in particle size and not particle charge.
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Table 3.3: Zeta potential of liposomes prepared with triclosan
Values are mean value of 3 independently prepared samples ± standard error.
3.3.4 Phospholipid concentration of liposome formulations
Figure 3.5 shows the phospholipid concentration of the liposome formulations, com-
pared to the expected concentration, assuming that 100 % of the starting material
was incorporated into the final product. The expected phospholipid concentration
was 0.875 mg/mL, since this was the concentration of PC that is present in the initial
formulation. Some phospholipid was lost in all cases, however this varied depending
on the formulation. The mean phospholipid concentration decreased after extrusion
to form SUVs for all formulations apart from T50, however this was within the ex-
perimental error for all cases apart from T500 MLVs and SUVs . There was a small
decrease in T50 and T100 phospholipid concentration compared to T0, however this
was again within the experimental error. The phospholipid concentration of formula-
tions T300 and T500 were the lowest, with a loss of 83-94 % of the total phospholipid.
Therefore, the phospholipid concentration of the final product was affected negatively
by including a triclosan concentration of 300µg or higher in the liposome formulation.
3.3.5 Determination of triclosan concentration
3.3.5.1 Analytical wavelength
The analytical wavelength was selected based on the UV absorbance spectrum of
triclosan at wavelengths 220-500 nm, which is shown in Figure 3.6. A maximum
absorbance was observed at 285 nm and therefore the selected optimum detection
wavelength was 285 nm.
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Figure 3.5: Phospholipid concentration of liposome suspensions. Liposome
MLVs and SUVs containing various concentrations of triclosan (0, 50, 100, 300 and
500µg/mL) were prepared and the concentration of phospholipids was measured us-
ing a phospholipid assay kit. The graph shows the mean phospholipid concentration,
compared to the concentration that would be expected (red bars), assuming 100 %
incorporation. Error bars show the standard error of 3 independently prepared sam-
ples.
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Figure 3.6: UV absorbance spectrum of triclosan solution.
3.3.5.2 Calibration curve
Triclosan solutions were analysed using HPLC and a peak was observed on the chro-
matorgram at retention time (RT) 6 min, with no other peaks observed. A calibration
curve for the integrated area under this peak was produced for 10 concentrations of
standard triclosan solutions (1, 2, 5, 10 20, 30, 40, 50, 75 and 100 µg/mL) and is
shown in Figure 3.7. This shows good linearity within the concentration range and
the correlation coefficient R2=0.9974 was considered acceptable.
3.3.5.3 Triclosan concentration of liposome formulations
Liposome formulations were analysed in the same way as the triclosan standard so-
lutions and a peak was again observed at RT 6 min. Chromatograms of liposomes
containing no triclosan (T0) did not have a peak at this RT. As a control measure,
liposome samples containing triclosan were spiked with standard triclosan solution,
and a single peak at RT 6 min was still observed, suggesting that the peak seen in
liposome samples was representative of the triclosan included in the formulation.
Figure 3.8 shows the triclosan concentration of liposome formulations, compared
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Figure 3.7: Calibration curve of triclosan concentration against integrated
HPLC peak values. Standard solutions of triclosan were prepared and analysed
using HPLC. The graph shows the integrated values of peaks observed at reten-
tion time 6 min for each concentration. Dashed line shows linear regression plot
(y = 9.3987x,R2 = 0.9974).
with the theoretical maximum. T50 and T100 liposomes were within experimental
error of the theoretical 100 % encapsulation value, suggesting that no triclosan was
lost in these formulations. A small decrease was seen between MLVs and SUVs of
T50 and T100 liposomes, however these were within the experimental error. T300
and T500 liposomes had a lower than expected triclosan concentration, with T500
SUVs having the lowest (21.6 ± 2.3 µg/mL). T500 MLVs had a comparable triclosan
concentration to T100 MLVs, however this was a much lower proportion of the overall
triclosan added (23 % compared to 117 % for T100 MLVs). Additionally, the T100
formulation retained most of the triclosan once extruded to SUVs, whereas a decrease
was seen in T500 SUV compared to T500 MLVs.
The HPLC results suggested that the maximum concentration of triclosan that
could be incorporated into this system was around 100 µg/mL, even if more triclosan
is added to the initial formulation. This is twice the value of the MBEC of tri-
closan against the bacteria of interest (Chapter 2, Section 2.3.2.3) and more than
10 times the MIC (Chapter 2, Section 2.3.2.1), suggesting that a clinically relevant
concentration of triclosan could be incorporated into these liposomes.
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Figure 3.8: Triclosan concentration of liposome suspensions. Liposome
MLVs and SUVs containing various concentrations of triclosan (0, 50, 100, 300 and
500µg/mL) were prepared and the triclosan concentration was measured using HPLC.
The graph shows the triclosan concentration, compared to the concentration that
would be expected (red bars), assuming 100 % incorporation. Error bars show the
standard error of 3 independently prepared samples.
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Table 3.4: Triclosan:phospholipid ratio of liposome formulations.
Values are mean value of 3 independently prepared samples ± standard error.
3.3.6 Triclosan:phospholipid ratio
The results of the HPLC analysis and phospholipid assay were compiled to obtain a
ratio of triclosan:phospholipid found in the different liposome formulations. This is
summarised in Table 3.4. The ratio was similar for T50 and T100 liposomes, with
the MLVs having a ratio of 0.13-0.17 and SUVs having a ratio of 0.10-0.13. T300 and
T500 liposomes had a higher ratio of triclosan:phospholipid, with MLVs having the
highest ratio (0.60-0.78). This was halved when MLVs were extruded to SUVs.
These analyses suggest that although a higher triclosan loading concentration
will not result in a higher triclosan concentration overall (see Section 3.3.5.3), it
does result in a higher ratio of triclosan:phospholipid, owing to the reduction in
phospholipid concentration seen in Section 3.3.4. This may have implications for the
overall membrane structure and therapeutic efficacy of the liposomes.
3.3.7 Antimicrobial efficacy of liposomes
Bacteria were incubated with triclosan loaded lipsomes and the antimicrobial efficacy
of the different liposomal formulations was assessed. Table 3.5 shows the parame-
ters derived from growth curves of E. faecalis and S. anginosus with the liposome
formulations.
Liposomes containing no triclosan did not change any of the growth parameters,
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Table 3.5: Growth parameters of Enterococcus faecalis (top) and Strepto-
coccus anginosus (bottom) with triclosan-loaded liposomes.
Bacteria were grown in BHI with liposomes in a 96-well plate for 20 h. Length of lag
phase (λ), maximum growth rate (µ) and maximum absorbance value (A) of growth
curves are shown. (“SEM”= standard error of the mean of 3 independent experiments,
“sig.”= significance of difference in means compared to bacteria in BHI:“ns”= P > 0.05,
*= P < 0.05, ** =P < 0.01, ***=P < 0.001)
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neither did those loaded with 50µg/mL triclosan. E. faecalis incubated with lipo-
somes loaded with 100µg/mL triclosan showed some changes in growth: a significant
reduction in µ was seen with MLVs and A was reduced with SUVs, although not
significantly so. These effects were not seen in S. anginosus with the same liposomal
formulations. For liposomal formulations with a loading dose of 300 and 500 µg/mL,
some differences in the growth parameters were seen. E. faecalis had a significant
decrease in A with all but T500 SUVs, and these formulations also had no measurable
λ or µ, suggesting that growth was inhibited in these conditions. For S. anginosus
growth, only the MLVs of T300 and T500 caused a significant decrease in A, however
no measurable λ or µ was derived from any of these 4 formulations.
These results indicate that liposomes formulated with a loading dose of 300 or
500µg/mL of triclosan (T300 and T500) and not extruded (MLVs) showed the great-
est inhibitory effect against both bacterial species in vitro over the time period tested.
3.4 Discussion
Liposomes composed of PC and C were prepared with the antimicrobial drug triclosan
and assessed for their suitability for delivery of the drug.
Triclosan is a hydrophobic molecule with logP=4.76 (National Center for Biotech-
nology Information, 2005) so it was assumed that triclosan would integrate into
the lipid bilayer of the liposome. It had been observed previously that liposomes
containing hydrophobic molecules, anthracene, adamantane and anthraquinone form
larger vesicles compared to control liposomes with no compound (Barlow-Myers 2017,
MChem dissertation). The position of the drug in the membrane may affect the phos-
pholipid packing, resulting in a change in bilayer curvature and therefore liposome
size. This study observes a reduction in liposome MLV size with increased drug
loading, suggesting that triclosan may cause an increased curvature of the bilayer.
A study by Guille´n et al. (2004) indicated that triclosan incorporated into a PC
bilayer membrane is positioned in the upper region of the phospholipid membrane,
with the hydroxyl group residing in the vicinity of the C=O/C2 carbon atoms of the
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acyl chain of the phospholoipid. Knyght et al. (2016) observed other hydrophobic
antimicrobial agents that reside near the headgroups of phospholipids and cause an
increase in the thickness of the headgroup region of phospholipid monolayers. This,
alongside the data from this chapter, may indicate that the decrease observed in li-
posome size is associated with a higher proportion of triclosan incorporated near the
phospholipid headgroup in the membrane, resulting in a larger headgroup region and
a higher degree of curvature in the vesicle-forming bilayer. This is supported by the
correlation of a smaller hydrodynamic diameter in T300 and T500 MLVs to a higher
triclosan:phospholipid ratio.
Liposome MLVs prepared with a higher concentration of triclosan had a hydro-
dynamic diameter and PDI more similar to their extruded counterparts than those of
control liposomes with no triclosan. A difference of 138 nm in mean size between T500
MLVs and SUVs, however, may have an effect on the clinical efficacy of these lipo-
somes and so for the methodology used, liposome extrusion may still be a crucial step
in the formulation process. Generally, liposomes between 70-150 nm are employed in
systemic therapeutic delivery (Allen and Cullis, 2004), as they are large enough to
encapsulate clinically relevant concentration of drugs but small enough to circulate
without becoming trapped in tissue microvasculature, and penetrate through pores
and gaps in the vascular endothelium associated with areas of inflammation (Hobbs
et al., 1998; Klimuk et al., 1999). Local delivery eliminates some of the challenges
associated with systemic delivery and the physical barriers for antimicrobial deliv-
ery within the decellularised root canal include dentine tubules of diameter 2-4µm
(Schilke et al., 2000) and penetration of the bacterial biofilm. Biofilms contain chan-
nels for the transport of water and nutrients, and work by Drury et al. (1993) showed
that silicone beads with diameter 1000 nm could diffuse readily through these chan-
nels: a mechanism that has been subsequently studied for assessing the flow rate
within biofilms (Evans, 2003). It is probable, therefore, that the liposomes produced
in this work are physically small enough to migrate into dentinal tubules and pene-
trate a bacterial biofilm for local delivery of antimicrobials.
The results of the bacterial growth curves with liposomes in this study shows
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that both MLVs and SUVs of T300 and T500 liposomes have a bacteriostatic effect
on planktonically grown E. faecalis and S. anginosus, with MLVs having slightly
greater efficacy. This suggests that the slightly larger hydrodynamic diameter does
not have a negative impact on antimicrobial drug delivery in this setting, although
there are other factors, such as phospholipid concentration, triclosan concentration
and triclosan:phospholipid ratio to consider in the assessment of antimicrobial efficacy.
Additionally, liposome size may have more of a bearing on biofilm penetration, which
was not assessed in this instance.
A phospholipid quantification assay was used to confirm observations that some
of the phospholipid membrane is unable to be resuspended from the glassware during
liposome preparation. This confirmed that up to 86 % of the phospholipids were lost
in MLV preparation (T300) and 93 % in SUV preparation (T500). This suggests a
change in the membrane properties when triclosan is added that inhibits the hydration
of the lipid film, however the mechanism for this is not clear. Lasic and Barenholz
(1996) suggest that difficulty in hydrating lipid films could indicate the formation of
nonbilayered phases. This may be driven by the hypothesised increase in headgroup
size of PC due to triclosan binding, that could induce a polymorphic phase transition
of the lipid membrane. Further analysis of the lipid film and the lipid particles
produced would be required to assess this, using techniques such as Phosphorus-31
nuclear magnetic resonance (Seelig, 1978).
The method used to assess phospholipid concentration only detects choline from
phospholipids and does not give any information on the cholesterol composition of
the liposomes and whether this is different between formulations. Other studies have
shown a slight increase in liposome size when cholesterol is added to PC liposomes
(De Kruijff et al., 1975; Lee et al., 2005b), and so a change in cholesterol concentration
could contribute to the different sizes observed in the different liposomes formulations.
Previous changes in size due to cholesterol incorporation, however, were not as great
as observed in this work, and it is likely that the triclosan concentration plays a
greater role, as previously discussed.
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Triclosan concentration of liposomes showed a similar overall trend to phospho-
lipid concentration, in that adding 300 or 500µg/mL of triclosan into the initial
formulation resulted in a much lower yield in the final product. This suggests that
triclosan is incorporated into the lipid film that cannot be resuspended using the
current methodology, however the amount of triclosan lost was not proportional
to the amount of phospholipid lost. This can be seen when calculating the tri-
closan:phospholipid ratio, which is higher for T300 and T500 liposomes than for T50
and T100 liposomes. This suggests that a higher drug:lipid ratio may be achieved by
incorporating a higher drug concentration, but this may also cause changes to occur
in the lipid film, leading to a loss of materials. Further work should look at liposomes
with starting triclosan concentrations between 100 and 300µg/mL to try to iden-
tify an optimal loading concentration for maximum drug:lipid ratio and minimum
material loss.
The importance of the drug:lipid ratio is apparent when considering the antimicro-
bial efficacy. For the growth experiments, the liposomes were diluted 1:9 in bacterial
suspension, resulting in a mean total triclosan concentration of approximately 8, 12,
6 and 11 µg/mL for T50, T100, T300 and T500 MLVs respectively and 7, 10, 4 and
2 µg/mL for T50, T100, T300 and T500 SUVs respectively, according to the triclosan
concentration measurements. It would therefore be expected that all liposome MLV
formulations and both T50 and T100 SUVs have antimicrobial potential, given that
the minimum inhibitory concentration (MIC) of triclosan is 6.25µg/mL (Chapter 2,
Section 2.3.2.1). This was not the case, and only T300 and T500 liposomes had a
significant effect on the growth of the bacteria, with the MLVs of these formulations
being the most effective and the T300 SUVs showing inhibition of E. faecalis growth,
despite having a triclosan concentration below the MIC.
The apparent lack of correlation between drug concentration in liposomes and
antimicrobial efficacy may be accounted for by the triclosan:phospholipid ratio of
the liposomes. The bioavailability of drugs is reduced when they are loaded into
liposomes, and will only be active when it released from the lipid bilayer (Bozzuto
and Molinari, 2015). It is therefore possible that a higher local concentration of
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triclosan within the liposomal membrane leads to better bioavailability of the drug,
and can even lower the MIC required in the system. For liposomes with a lower
triclosan:phospholipid ratio but a higher total triclosan concentration, it is possible
that a concentration of triclosan below the MIC is released over the 20 h incubation
period and so no antimicrobial effect is observed. Although a slow release of drug
over time may be desirable for a dental filling material, an initial release above the
MIC is necessary to inhibit growth and prevent re-colonisation of the treated dental
cavity. It has been suggested that the drug:lipid ratio will have an impact on the
release profile of the liposomes, with a higher ratio being associated with more sus-
tained release and higher drug retention, possibly mediated by the presence of drug
precipitates in the liposomes, as was seen in the case of vincristine-loaded liposomes
by Johnston et al. (2006). Further work is needed to assess the release profile of
the liposomes prepared in this chapter, however this initial work suggests that a tri-
closan:phospholipid ratio higher than 0.3 is needed to achieve an antimicrobial effect
in the first 20 h of treatement. A higher drug:lipid ratio is preferable in systemic
drug delivery in order to minimise the amount of lipid that is required to deliver
clinically relavent drug doses (Straubinger and Balasubramanian, 2005; Cern et al.,
2014), however this may not be as crucial for local delivery in this instance.
Liposomes were prepared as MLVs or SUVs for this work. The production of
SUVs through extrusion is a limiting step in liposome production in terms of time
and financial cost, and so it would be advantageous to use MLVs in future drug
delivery formulations. Comparison of MLVs and SUVs in this study showed that
there was no reduction in antimicrobial efficacy of MLVs, and in fact MLVs of T300
and T500 liposomes were more effective than SUVs against both species of bacteria.
It is therefore worth considering the use of MLVs instead of SUVs for antimicrobial
delivery in endodontic therapy. It would, however, be necessary to consider other
factors, such as the delivery of MLVs to bacterial biofilms (potentially residing within
narrow dentine tubules), MLV stability compared to SUVs as well as their efficacy
once incorporated into a suitable dental filling material.
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3.5 Conclusions
It has been shown that triclosan can be incorporated into PC:C liposomes, the as-
sembled size of which are dependent upon the initial loading dose of the drug. Quan-
tification of the encapsulated triclosan suggested that there is a limit to the amount
that may be encapsulated, however this limit is above the concentration required
to eradicate two oral pathogens, according to data from the previous chapter. In-
cubation of the liposomes with the bacteria confirmed that the liposomes had an
antimicrobial effect, and this was seen predominantly in T300 and T500 liposomes
that had not been extruded (MLVs). These formulations had a high drug:lipid ratio,
which indicates that the membrane composition of the liposomes is important as well
as the overall concentration of the drug within the system. The high loss of materials
observed in these formulations is not desirable, but these results may inform more
precise methods such as microfluidic preparation of liposomes in the optimum ratio
of drug:lipid that should be used. Further work will assess the suitability of T300
and T500 liposomes to be incorporated into a hydrogel for endodontic drug delivery.
Chapter 4
Characterisation of a Hydrogel for
the Delivery of Antimicrobial
Liposomes
4.1 Introduction
Hydrogels are cross-linked networks of hydrophilic polymers that have solid-like prop-
erties but may contain high amounts of water or biological fluids (Peppas et al., 2000).
They are considered for local drug delivery in a number of biomedical applications,
as their physical properties are tunable and they have potential to carry and deliver
aqueous drug solutions. Hydrophobic drugs may not be suitable for incorporation
into a hydrogel, however the previous chapter has shown that a hydrophobic an-
timicrobial, triclosan, can be incorporated into an aqueous dispersal of liposomes
and retain its antimicrobial properties against oral pathogenic bacteria. A hydrogel
may therefore be a suitable carrier of triclosan liposomes for use as a local dental
medicament.
Methyl cellulose (MC) is a water-soluble, naturally derived “biopolymer” that is
biocompatible and biodegradable, making it favourable for biomedical applications
(Grijalvo et al., 2016). It is produced from the modification of cellulose and its struc-
ture is shown in Figure 4.1. Natural, unmodified cellulose is hydrophilic in chemical
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Figure 4.1: Structure of cellulose (left) and methyl cellulose (right)
structure but is water-insoluble due to strong intermolecular hydrogen bonding. Sol-
ubility can be achieved by substituting a certain proportion of the hydroxyl groups
with hydrophobic groups: in MC these are methyl groups. To achieve water sol-
ubility, the degree of substitution (DS) must be high enough to prevent extensive
intramolecular hydrogen bonding but low enough such that enough hydrophilic hy-
droxyl groups remain to hydrogen bond with water to confer solubility. The DS of
cellulose that has undergone 100 % substitution is 3, as there are 3 reactive hydroxyl
groups per anhydroglucose unit and all 3 have been substituted. The optimum DS
for water solubility of hydrophobically modified cellulose is typically 1.7-2.0 (Li et al.,
2001). MC has reverse thermal gelling properties in aqueous solution. When the
temperature of the solution rises above a critical temperature, the polymer forms
a physical hydrogel due to hydrophobic interactions between the methyl groups (Li
et al., 2001). Increasing temperature is believed to cause distortion in the enclosed
structures formed by water molecules that surround the hydrophobic methyl groups.
This causes increased phase separation between hydrophobic and hydrophilic groups
and results in the formation of hydrophobic aggregates. This effect is reversed when
the temperature is decreased again. The gelation temperature of MC is dependent
upon the polymer concentration, with a higher concentration resulting in a lower
gelation temperature. At maximum soluble concentration (10 % w/w), methyl cellu-
lose is reported to gel at around 30 ◦C (Sigma, 1997; Takahashi et al., 2001). Gelation
can also be modified by the addition of anions into the system, either by salt addition
or an anionic polymer (Li et al., 2001; Xu et al., 2004).
This chapter will examine the suitability of a MC hydrogel to carry and deliver
antimicrobial liposomes. The rheological properties of this system will be determined,
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Table 4.1: Summary of liposome formulations prepared for methyl cellulose
incorporation.
including the effect of liposome incorporation, and the antimicrobial properties of the
liposomes in the hydrogel also assessed.
4.2 Materials and methods
4.2.1 Preparation of methyl cellulose solutions containing li-
posomes
4.2.1.1 Liposome preparation
Multilamellar vesicle (MLV) and small unilamellar vesicle (SUV) liposomes were pre-
pared as described in Chapter 3, Section 3.2.1. Liposomes containing no triclosan
(T0 MLV and T0 SUV) and those prepared with 300 µg/mL and 500µg/mL triclosan
(T300/T500 MLV and T300/T500 SUV) were used in this chapter: a summary is
shown in Table 4.1.
4.2.1.2 Incorporation of liposomes into methyl cellulose solution
Liposome dispersions were placed in a waterbath at 80 ◦C for 10 min before methyl
cellulose (MC, 15 cP) was added (10 % w/w). The suspension was gently agitated
until the MC powder appeared evenly dispersed. The suspension was then placed at 4
◦C for 24 h under gentle agitation to allow for dissolution of the MC. Control solutions
were prepared as above, but with H2O used in place of the liposome dispersions.
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4.2.2 Rheological analyses of methyl cellulose with liposomes
4.2.2.1 Rheometry apparatus
Rheological properties of MC solutions were measured using a Bohlin C-VOR 200
rheometer attached to a Bohlin KTB 30 waterbath for temperature control of the
lower plate. A 40 mm parallel plate geometry was used for sample measurement and
data were collected using Bohlin R6.51.0.3 software and then exported to Microsoft
Excel for analysis.
4.2.2.2 Sample loading
MC solutions were equilibrated at ambient temperature before loading onto the
rheometer. Using a 1 mL syringe, 0.8 mL of solution was applied to the lower plate of
the rheometer, which had been equilibrated at the chosen measurement temperature.
The upper plate was then lowered onto the sample (speed set to maximum) to a gap
width of 0.5 mm, and any excess sample was removed where necessary. A new sample
was loaded for each rheological test performed.
4.2.2.3 Viscosity
The viscosity of MC solutions containing T0 MLVs, T0 SUVs and H2O only was
measured. Shear viscosity (Pa.s) was measured at increasing shear rates of 0.15-
2000 s−1, with 30 readings taken at logarithmic intervals. The initial delay time for
sample measurement was 100 s, set to decrease at each sample reading. All viscosity
measurements were performed at 25 ◦C. The exact parameters set on the instrument
are shown in Table 4.2A. Ambient temperature was 24-26 ◦C for these measurements.
4.2.2.4 Amplitude-dependent viscoelasticity
An amplitude sweep was performed in order to ascertain the linear viscoelastic (LVE)
range at 25 ◦C of MC solutions containg T0 MLVs, T0 SUVs, and H2O only. The
oscillatory frequency was set to 1 Hz and the strain was increased from 0.01-100. The
elastic modulus (G’) and viscous modulus (G”) were plotted against strain, and a
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strain value within the LVE range was selected for further viscoelasticity measure-
ments. The parameters for the amplitude sweep are shown in Table 4.2B. Ambient
temperature was 24-26 ◦C for these measurements.
4.2.2.5 Temperature-dependent viscoelasticity
A temperature sweep was performed in order to estimate the gelation temperature
of the MC solutions containing T0 MLVs, T0 SUVs and H2O only. The rheometer
was set to a constant oscillatory frequency (1 Hz) and amplitude (strain=0.5) and
the temperature was increased from 25-55 ◦C at a rate of 2 ◦C/min. G’ and G” were
plotted against temperature in order to assess the temperature-dependent viscoelastic
properties of the MC samples. The parameters for the temeperature sweep are shown
in Table 4.2C. Ambient temperature was 24-26 ◦C for these measurements.
4.2.2.6 Time-dependent viscoelasticity at 3 constant temperatures
Viscoelasticity was also measured as a function of time at a constant temperature,
oscillatory frequency (1 Hz) and amplitude (strain=0.5). This measurement was
performed on T300 MLVs and T300 SUVs at 30, 35 and 40 ◦C for 20 min at each
temperature. The lower plate of the rheometer was allowed to equilibrate to the
set temperature before the sample was placed on the plate, as described in Section
4.2.2.2. The upper plate was then lowered onto the sample, taking approximately 50
s, and the measurement was started. G’ and G” were plotted against measurement
time in order to assess the viscoelastic properties of the MC samples over time at
specific temperatures. The parameters for these measurements are shown in Table
4.2D. Ambient temperature was 31-33 ◦C for these measurements.
4.2.3 Release of components from hydrogel
Measurement of liposome release from MC was done under non-sink conditions.
MC solutions were prepared (10 % w/w) containing liposome formulations T300
MLV/SUV, as described in Section 4.2.1. MC solutions containing triclosan only
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Table 4.2: Rheometer parameters.
Instrument parameters for rheological analysis of (A) viscosity, (B) amplitude-dependent
viscoelasticity, (C) temperature dependent viscoelasticity and (D) time-dependent
viscoelasticity.
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(100µg/mL) and H2O only were also prepared. The solutions were placed in a 24-
well plate (0.2 g/well) and then the plate was placed in an incubator at 37 ◦C for
1 h until the solution had gelled. H2O (1 mL, heated to 37
◦C) was then added to
each well. A different well was prepared for each time point. For the time point 0 h,
the aqueous phase was immediately removed from the wells, leaving the gel behind,
and the plate was returned to the incubator for subsequent time points. At times 2,
8, 24, 96 and 168 h, the aqueous phase was removed from the wells, leaving the gel
behind. The removed aqueous phase was then analysed for triclosan concentration
and phospholipid concentration.
4.2.3.1 Triclosan quantification using HPLC
An aliquot of the aqueous phase from the release assay was added to methanol (1:1)
and then an HPLC assay was performed as detailed in Chapter 3, Section 3.2.5.
4.2.3.2 Phospholipid quantification using phospholipid assay
An aliquot of the aqueous phase from the release assay was added to 0.1 % Triton
X-100 (1:1) and then the phospholipid assay was performed as detailed in Chapter
3, Section 3.2.4.
4.2.4 Antimicrobial efficacy of methyl cellulose loaded with
triclosan liposomes
The antimicrobial efficacy of liposome-loaded MC was assessed by analysing the
growth of E. faecalis and S. anginosus in the presence of the hydrogel. MC solu-
tions containing liposomes were prepared as described in Section 4.2.1. Solutions
containing T0 MLV/SUVs, T300 MLV/SUVs and T500 MLV/SUVs were prepared
as well as control solutions containing 500µg/mL triclosan in 1 % IPA and 1 % IPA
only.
MC solutions at 4 ◦C were pipetted into a 96-well plate (20 µL/well) and then the
plate was incubated at 37 ◦C for 20 min until the solutions had gelled. Overnight
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broth cultures of E. faecalis or S. anginosus, prepared as previously described, were
diluted in BHI to obtain an optical density of 0.08-0.1 at 600 nm. Two further 10-
fold dilutions were then prepared and the resulting bacterial suspension was pipetted
onto the wells containing MC hydrogels (180 µL/well). The plate was incubated in a
plate reader (FLUOstar Omega, BMG Labtech, Ortenberg, Germany) at 37 ◦C in 5
% CO2 for 20 h. The absorbance at 600 nm was measured every 1 h and the plate
was shaken at 40 RPM for 30 s before each measurement.
The resulting bacterial growth curves were analysed as previously described in
Chapter 2, Section 2.2.3.3.
4.3 Results
4.3.1 Rheological properties of methyl cellulose with lipo-
somes
The rheological properties of MC solutions were measured as well as the effect of
liposome MLV and SUV incorporation into the polymer solution.
4.3.1.1 Shear viscosity
Shear viscosity of MC solutions was measured at 25 ◦C (Figure 4.2). Control MC
solutions (H2O only) had a viscosity of 10±1 Pa.s at 0.15 s−1, decreasing to 0.6±0.1
Pa.s at 2000 s−1. Measurements of solutions containing MLVs or SUVs were within
the experimental error of the control solutions, suggesting that the viscosity of MC
solution was unaffected by the incorporation of liposomes, and that there was no
difference seen between solutions containing MLVs or SUVs.
These results indicate that MC is shear-thinning when in solution at 25 ◦C, and
the shear viscosity is unaffected by the addition of liposome MLVs or SUVs.
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Figure 4.2: Shear viscosity of methyl cellulose with Liposomes. Liposome
MLVs and SUVs were prepared and incorporated into a 10 % w/w MC solution. The
viscosity of these solutions was measured as a function of increasing shear rate on
a rotational rheometer. Graph shows mean shear viscosity with standard error of 3
independently prepared samples.
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Figure 4.3: Amplitude-dependent viscoelasticity of methyl cellulose with
Liposomes. Liposome MLVs and SUVs were prepared and incorporated into a 10
% w/w MC solution. The viscoelasticity was measured as a function of strain on a
rotational rheometer. Graph shows the mean G’ (elastic modulus) and G” (viscous
modulus) with standard error of 3 independently prepared samples.
4.3.1.2 Amplitude-dependent viscoelasticity
The viscoelasticity at 25 ◦C of MC solutions containing liposomes was measured as
a function of strain (Figure 4.3). In all measurements, the elastic modulus (G’) was
lower than the viscous modulus (G”) at 25 ◦C, confirming that MC was a viscoelastic
liquid at this temperature. The G’ of all samples decreased with increasing strain,
however the rate of decrease appeared greater after the strain increased above 0.8.
The LVE range of the solution was therefore estimated to be under a strain value
of 0.8. The measurements for MC containing MLVs and SUVs were within the
experimental error of the control solutions, suggesting that liposomal incorporation
did not affect the amplitude-dependent viscoelasticity of MC solution at 25 ◦C.
These data suggest that the amplitude-dependent viscoelasticity of MC was unaf-
fected by liposome incorporation at strain values of 0.1-100, and that the LVE range
was below 0.8. A strain value of 0.5 was therefore selected for further viscoelasticity
measurements.
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4.3.1.3 Temperature-dependent viscoelasticity
The viscoelasticity of MC was measured as the temperature was increased from 25-
55 ◦C in order to assess the effect of liposomes on the gelation of MC solution (Figure
4.4). At 25 ◦C, G” was greater than G’, indicating that MC was a liquid. As
temperature increased, G’ was constant until temperature reached 32 ◦C, where G’
began to increase. At 37.7 ◦C, G’ became greater than G”, indicating that the
solution had gelled at this temperature. MC containing MLVs and SUVs showed
similar results, with G’ exceeding G” at 38.5 ◦C.
These measurements suggested that liposome incorporation did not inhibit the
thermo-responsive gelation mechanism of MC, however the gelation temperature with
liposomes was higher than that of MC alone. It was considered that this difference
may have been a function of time rather than temperature, as the temperature was
steadily increased over the duration of the measurement. It was therefore decided to
measure the viscoelasticity of the liposome-loaded MC over time whilst maintaining
a constant temperature, in order to investigate this hypothesis.
4.3.1.4 Time-dependent viscoelasticity at 3 constant temperatures
Viscoelasticity was measured as a function of time at 30, 35 and 40 ◦C. Figure 4.5
shows the results of these measurements. The time shown does not include the
approximate 50 s it took to lower the top plate before a measurement was taken.
At 30 ◦C, MC behaved as a solution, with G’ lower than G”. G’ increased over
the 20 min measurement period, becoming equal to, but not greater than, G” by the
end of the measurement.
At 35 ◦C, G’ had increased to within the experimental error of the G” in the 50 s
pre-measurement. This continued to increase and became greater than G” at around
250 s of measurement time. This suggests that MC gels at 35 ◦C, and takes around
300 s to do so.
At 40 ◦C, G’ was equal to G” by the time the measurement has started and
continued to increase above G”. This suggests that MC forms a gel faster at 40 ◦C,
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Figure 4.4: Temperature-dependent viscoelasticity of methyl cellulose with
liposomes. Liposome MLVs and SUVs were prepared and incorporated into a 10 %
w/w MC solution. The viscoelasticity was measured as a function of temperature on
a rotational rheometer. Graph shows the mean G’ (elastic modulus) and G” (viscous
modulus) of 3 independently prepared samples. For clarity, error bars are shown for
every 5th measurement point. Table insert indicates the first temperature point at
which mean G’ is greater than mean G” for each formulation.
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Figure 4.5: Time-dependent viscoelasticity of methylcellulose with liposomes.
Liposomes were incorporated into a 10 % w/w methyl cellulose solution and the viscoelas-
ticity was measured for 20 minutes at 30, 35 and 40 ◦C on a rotational rheometer. Graphs
show G’ and G” of methyl cellulose with T300 MLVs and SUVs. For clarity, every 5th
measurement is shown only. Error bars show standard error of 3 independently produced
samples.
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taking around 50 s, and that the gel formed has a greater G’ than that of the gel
formed at 35 ◦C, within the 20 min measurement time.
These data suggest that MC containing T300 liposomes will gel at 30-35 ◦C,
however the time-to-gel and the overall physical properties of the gel are temperature-
dependent, within the temperature range tested.
4.3.2 Release of components from methyl cellulose
The release of phospholipids and triclosan from MC hydrogels was measured in or-
der to estimate liposome release from the system. Phospholipid release could not
be measured as the majority of samples were below the detection limit of the assay
(2µmol/L). The triclosan concentration was measured using HPLC and is shown in
Figure 4.6. Hydrogel containing only triclosan did not release a detectable concen-
tration of triclosan over 168 h, however MC containing triclosan MLVs and SUVs did
release around 20 % of the original triclosan added over 168 h. A time-dependent
increase in released triclosan is seen from 0-24 h, but the concentration remains the
same from 24-168 h. Hydrogels containing MLVs released more triclosan than those
containing SUVs, however there was high variability on these measurements and the
values for MLVs and SUVs were within the experimental error of one another. These
data suggest that triclosan is released from MC, but only when loaded into liposomes
and there is no difference in the release profiles of MLV or SUV liposomes.
4.3.3 Antimicrobial properties of methyl cellulose with lipo-
somes
Bacteria were incubated with MC hydrogels containing triclosan liposomes and the
bacterial growth was assessed. T300 and T500 liposomes were selected for analysis as
they showed the greatest antimicrobial activity when tested as liposomal suspensions
(Chapter 3, Section 3.3.7). Figures 4.7 and 4.8 show the growth curves obtained from
these analyses and Table 4.3 summarises the parameters derived from these growth
curves.
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Figure 4.6: Release of triclosan from methyl cellulose hydrogel. Triclosan
liposomes were incorporated into 10 % (w/w) MC solution and this was incubated
at 37 ◦C for 168 h in H2O. The H2O was removed at 6 timepoints and analysed
for the presence of triclosan. Graph shows the mean % of triclosan released from
gels containing MLVs, SUVs or triclosan only. Error bars show standard error of 3
independently prepared samples. Where error bars are not visible, error lies within
the point height.
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Figure 4.7: Growth of Enterococcus faecalis with liposomes in MC hydrogel.
Liposomes prepared with 0 µg/mL (A), 300 µg/mL (B) and 500 µg/mL (C) of triclosan
were incorporated into a 10 % w/w methyl cellulose solution and incubated with a broth
culture of E. faecalis. Graphs show mean optical density (OD, measured at 600 nm) of
the suspensions over 20 h, compared to controls of bacterial culture alone, MC containing
triclosan only, and MC containg 1 % IPA. Error bars show standard error of 3 independent
experiments.
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Figure 4.8: Growth of Streptococcus anginosus with liposomes in MC hydrogel.
Liposomes prepared with 0 µg/mL (A), 300 µg/mL (B) and 500 µg/mL (C) of triclosan
were incorporated into a 10 % w/w methyl cellulose solution and incubated with a broth
culture of S. anginosus. Graphs show mean optical density (OD, measured at 600 nm) of
the suspensions over 20 h, compared to controls of bacterial culture alone, MC containing
triclosan only, and MC containg 1 % IPA. Error bars show standard error of 3 independent
experiments.
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Table 4.3: Growth parameters of Enterococcus faecalis (top) and Streptococcus angi-
nosus (bottom) with liposomes in methyl cellulose.
Bacteria were grown in BHI in a 96-well plate with methyl cellulose hydrogel formulations
for 20 h. Length of lag phase (λ), maximum growth rate (µ) and maximum absorbance
value (A) of growth curves are shown. (“SEM”= standard error of the mean of 3
independent experiments, “sig.”= significance of difference in means compared to bacteria
in BHI:“ns”= P > 0.05, *= P < 0.05, ** =P < 0.01, ***=P < 0.001).
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Bacterial growth was unaffected by MC containing T0 liposomes (Figures 4.7A
and 4.8A). E. faecalis growth rate (µ) with T300 SUVs was significantly decreased
(P = 0.04), however the maximum absorbance value (A) was not significantly lower
than controls. No inhibition of growth was observed with T300 SUVs against S. angi-
nosus or with T500 SUVs against either species. T300 and T500 MLVs caused
a reduction in maximum absorbance (A), which was significant against E. faecalis
(P = 0.02 and P = 0.04 respectively). These formulations did not significantly lower
the maximum absorbance of S. anginosus, however no definitive lag phase or growth
rate was identified, suggesting that growth was inhibited to some extent. MC contain-
ing triclosan only had no effect on bacterial growth of either species. These findings
suggest that triclosan is not effective when loaded into MC alone, but liposomal
triclosan shows antimicrobial efficacy, particularly against E. faecalis.
4.4 Discussion
MLVs and SUVs were loaded into a MC hydrogel to assess the suitability of this
material to carry and deliver antimicrobial liposomes to root canals. This novel
composite gel system has not previously been developed or tested for this use.
Rheological analyses confirmed that MC is a shear-thinning, viscoelastic liquid at
25 ◦C. This shear-thinning behaviour is typical in polymer solutions (Morris et al.,
1981) and has previously been observed in lower concentrations (2 % w/v) of MC
(Haque and Morris, 1993). The results obtained here suggest that a 10 % w/w MC
solution may be suitable for root canal injection, as it will decrease in viscosity as it
pushed through a syringe, however further study would be required to investigate how
the rheological data relate to practical use. Typically, the minimum diameter of a
prepared root is around 200 µm, based on the tip diameter of conventional endodontic
files (size 20 K-file and ProTaper F2), and so it would be advantageous to observe
if the solution could be extruded through a 27-gauge endodontic irrigation needle,
which has an internal diameter of 200 µm. In addition, it has not been investigated
what happens to the viscosity once the shear stress is removed, and whether the
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solution would flow freely into the root canal. No previous studies are available
in the literature that indicate the ideal physical properties an intracanal dressing
should achieve, however the maximum viscosity of MC was 10 Pa.s, and the viscosity
of Ca(OH)2 paste (the most commonly used intracanal medicament) is around 3.5
Pa.s (Estrela et al., 2001), suggesting that the viscosity of the solutions prepared in
this study may not be low enough for intracanal injection, depending on whether the
solution will return to its maximum viscosity after shear-thinning has occurred.
A 10 % MC solution was used, as this is the maximum soluble concentration of MC
in H2O, resulting in the lowest gelation temperature without further modification. If a
lower concentration of MC was required in order to lower the viscosity of MC solution
upon injection, the addition of saline to the system would allow for the maintenance
of a low gelation temperature whilst also lowering the MC concentration. Zuidema
et al. (2014) used 6 % MC in saline solution and obtained a gel with a G’ at 37 ◦C
that was comparable to the G’ of 10 % MC at 40 ◦C observed in this chapter. The
addition of chitosan also influences the gelation temperature of MC, when combined
with various salt solutions (Tang et al., 2010).
Addition of liposomes had no significant effect on the viscosity of MC solution.
No other studies were found on the effect of liposomes on MC rheology, however
Mourtas et al. (2009) investigated the effect of PC:C liposomes on the viscosity of hy-
droxyethylcellulose, which is another ether of cellulose, and observed a concentration-
dependent increase in viscosity when 5 mg/mL or 20 mg/mL liposomes were added
to the polymer solution. Another study by the same group concluded that liposome
size was not a contributing factor to these rheological differences (Mourtas et al.,
2008). The concentration added in this chapter was 1 mg/mL and so it is possible
that higher liposome concentrations would affect the viscosity. This should be inves-
tigated if it became apparent that a higher concentration of liposomes were required
for greater therapeutic efficacy. The lack of liposome size-dependent differences in
rheology agree with those of the 2008 study.
Temperature-dependent measurements suggested that MC formed a gel as the
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temperature increased above 37 ◦C and that liposomal MLVs and SUVs did not af-
fect the ability of MC to form a gel. A slight increase in gelation temperature was
observed in these samples when a temperature sweep was performed, however further
rheological tests suggested that the liposome/MC solutions gelled at 35 ◦C, taking
approximately 300 s to do so. This would suggest that the gelation temperature of
38.5 ◦C obtained from the temperature sweep was a result of increasing the temper-
ature at a rate of 2 ◦C/min and therefore not allowing the sample sufficient time to
equilibrate at each temperature. Generally, root canal medicaments do not need to
set in the same way as a restorative material (such as a sealant) because they have
no structural role, however the material must be able to fill the root canal whilst
avoiding extrusion through the root apex into the periapical tissue (Carrotte, 2004).
The “working time” is considered the time during which the medicament is phys-
ically malleable enough to be placed in the root canal before the the consistency
changes, and for currently used materials, is defined by the time it takes to observe
a 10 % shrinkage in material volume due to dehydration (International Organisation
of of Standardization, 2012). A study by Basrani et al. (2004) compared the working
time of MC (4000 cP, 1 %) containing calcium hydroxide, chlorhexidine, or a com-
bination of both, according to the ISO standards, and found a mean working time
of 92-128 min for the materials tested. The liposomal MC prepared in this chapter
did not use the same assessment criteria, but suggested that the working time was
much shorter, if this were to be defined as the time taken for the MC solution to
form a gel. Allan et al. (2001) showed that the working time for root canal sealants
increased greatly when they were placed in high humidity, similar to that found in
the oral cavity, suggesting that further experiments would need to assess the gelation
time of the hydrogel in high humididty, in order to assess the working time in a more
clinically relevant setting.
Time-dependent viscoelasticity measurements showed that MC with liposomes
gels at 35 ◦C and 40 ◦C, however the gel formed at 40 ◦C has a shorter gelation
time (∼50 s) and a higher G’, suggesting that a stronger gel is formed. Although
physiological temperature is considered to be 37 ◦C, there may be some fluctuations
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in intra-oral temperatures due to external stimuli. Barclay et al. (2005) measured
fluctuations in intra-oral temperature from 0-70 ◦C when cold and hot beverages were
consumed, however this variation was observed on front teeth, and the variation was
lower on pre-molars and molars. It is not clear how these temperature fluctuations
would translate to the intra-canal environment, however the temperature-sensitive
nature of the hydrogel may cause variation in the rheology of the gel over time in
vivo. It has not been studied how fluctuations in temperature and/or rheological
properties may affect the release profile of the gel, but premature burst release of
the liposomes due to an unstable rheology may diminish the long-term efficacy of the
material.
Overall, these rheological data suggest that MC is a shear-thinning, potentially
injectable solution at ambient temperature and will gel as the internal temperature
increases. Additionally, it could be used to carry liposomes for therapeutic purposes
as they do not significantly alter the rheological properties.
Release of triclosan from MC was measured over 168 h. These data suggested that
triclosan is released gradually over 24 h, but remains at the same concentration from
24-168 h. This may indicate that a maximum release of 20 % has been reached at
24 h, or that a longer incubation time is needed to observe further triclosan release.
This experiment measured release in non-sink conditions, where the aqueous phase
was left on the gel until the desired timepoint had been reached. This method will
be dependent on the partition coefficient of the drug between the gel and aqueous
phase, thus a maximum concentration of released triclosan may have been reached
due to the partition coefficient rather than the the release (Washington, 1989). Fol-
lowing endodontic preparation, the dentine tubules are proposed to contain residual
endodontic irrigants (NaOCl, water) as well as dentine fluid (Allan et al., 2001). Once
a medicament is placed and the dental crown is sealed, the remaining fluid is in a
contained area, where aqueous turnover around the material is limited, assuming no
coronal leakage occurs and that the apical foramen is sealed. A non-sink experiment
was therefore selected to be a closer representation of a clinical setting under these
assumptions. There are a lack of studies, however, evaluating aqueous flow (or lack
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thereof) within the filled root canal. Non-sink conditions have been used to measure
drug release from other endodontic materials, such as polymer coated drug devices
containing chlorhexidine tested by Lee et al. (2005a).
Phospholipid was not quantifiable in the assay used, suggesting that concentra-
tions below the detection limit of the kit were present in the aqueous phase of the
experiment. If the triclosan was released in the form of intact liposomes, it would
have been expected that comparable percentage of lipid would be released as that of
triclosan. This, however, was not the case, since this would have yielded high enough
concentrations to be detected by the assay. It is evident that liposomal encapsulation
is necessary for hydrogel release because triclosan that was loaded directly into the
gel was not released at all over the time period measured. This suggests that the
diffusion of triclosan within the system is modified by liposomal loading but it may
not be released in liposomal form. Further analyses may clarify the release mecha-
nism of triclosan from the gel. Park et al. (2013) used DLS to confirm the presence of
liposome-sized particles released from a cellulose hydrogel containing quertecin and
rutin-loaded liposomes: a method which could be employed for triclosan liposome re-
lease from MC. Others have used fluorescent probes to model liposomal drug release
and determine whether the compounds are released in liposomal form. Ruel-Garie´py
et al. (2002) loaded liposomes with a hydrophilic, fluorescent dye, carboxyfluoroscein,
and incorporated these into a chitosan-based hydrogel. Release was measured using
fluorescence spectroscopy and the addition of Triton to the released components re-
sulted in an increase in fluorescence, suggesting that the dye had been released from
the gel in liposomal form and that the addition of Triton had ruptured the liposomes,
resulting in an increase in fluorescence. The study also showed that liposome encap-
sulation resulted in a slower release of the dye compared to free dye alone, which is
the converse to the observations of the chapter. This suggests that hydrophilic drug
release may be slower upon liposome incorporation, but hydrophobic drugs, such as
triclosan, require liposome encaspulation in order to facilitate their release.
It was also demonstrated that drug-loaded liposomes incorporated into MC re-
tained their antimicrobial properties over 20 h and that this effect was greater in
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MLVs than SUVs. These results are similar to those obtained with liposomes in
suspension (Chapter 3, Section 3.3.7), suggesting that hydrogel incorporation does
not negatively impact the antimicrobial properties of the triclosan liposomes. The
reduction in growth of both bacteria was not as great with liposomes in MC as it
was with liposome suspensions. This may be because only a proportion of the drug
is released into the bacterial suspension over 24 h (as demonstrated in the gel release
experiment), whereas it is assumed that liposomes delivered in suspension will be
immediately dispersed into the bacterial broth. MC itself showed no antimicrobial
effect, neither did MC loaded with T0 (empty) liposomes. Additionally, triclosan
alone had no antimicrobial effect when incorporated into MC, compared to liposomal
triclosan. This may be explained by the previous experiment, showing that triclosan
is not released from MC unless it is incorporated into liposomes. Further work could
use the aqueous phase of the hydrogel release experiments to assess the antimicrobial
properties and elucidate whether the bacteria must be cultured with the gel or if the
released components alone can elicit an antimicrobial effect.
4.5 Conclusions
It has been shown that a MC hydrogel containing triclosan MLVs and SUVs has
rheological properties that may be suitable as an endodontic, intracanal medicament.
It is shear-thinning at ambient temperature, suggesting that it may be injectable,
and it forms a gel at physiological temperature. Triclosan liposomes are released
from the gel over time and MLVs loaded with 300 and 500 µg/mL triclosan had an
antimicrobial effect against two common pathogenic endodontic bacteria, particularly
E. faecalis, which is commonly associated with failed endodontic restorations. In the
gel system, the liposomes are essential for triclosan release to occur.
Chapter 5
Antimicrobial Efficacy of a
Triclosan Liposome-Loaded
Hydrogel in Endodontically
Prepared Human Root Canals
5.1 Introduction
Results from previous chapters have suggested that methyl cellulose (MC) hydrogel
containg triclosan-loaded liposomes inhibit the growth of two oral pathogens in vitro,
however this was assessed with planktonic bacterial growth in a well plate. Whilst in
vitro assays allow for greater control of experimental conditions, growing and treating
the bacteria in a clinically more relevant setting would give a better indication of the
material’s efficacy for its potential use as an intracanal medicament during endodontic
therapy. An ex vivo model of endodontic infection will therefore be developed to help
predict how well the material will perform in vivo as there may be some barriers to
delivery that cannot be accounted for during in vitro experiments.
It is well known that bacteria existing as a biofilm on a surface have greater poten-
tial to withstand antimicrobial treatment than those grown planktonically (Stewart,
2002): a characteristic that has been observed previously in Chapter 2. Even when
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grown as a biofilm in vitro, the substrate type must be considered, as bacteria cultured
on root dentine may display differences in attachment and biofilm formation com-
pared to those cultured on plastic. This is, in part, due to differences in the physical
properties of the substrates. The polystyrene used to produce tissue culture plastics
is smooth, with surface roughness (Ra) of around 0-0.007µm, whereas root dentine
roughness is 0.11-0.26µm, depending on the endodontic treatments used (Hatano
et al., 1999; Ari et al., 2004; Zeiger et al., 2013). Dentine is also porous, possessing
dentine tubules that extend perpendicular to the root surface, allowing for bacterial
migration and colonisation and ultimately providing a larger surface area for biofilm
formation (Section 1.3). This may result in a greater proportion of the biofilm that
is inaccessible for antimicrobial treatment and therefore decrease treatment efficacy.
As well as the physical properties of the dentine, root morphology is a challenge to
endodontic antimicrobial delivery. During endodontic preparation bacteria can evade
mechanical debridement and antimicrobial irrigation, residing in dentine tubules, isth-
muses and accessory canals (Carrotte, 2004). Root curvature and root calcification
may also restrict the working length during endodontic preparation and therefore
increase the areas where bacteria may reside undisturbed (Tang et al., 2011). Even
when preparation is relatively straightforward, typically prepared roots will have nar-
row diameters of 60-500 µm at the apex (based on the tip diameter of conventional
K-files and ProTaper endodontic files), depending on the original root dimensions.
It is therefore important to assess the efficacy of new treatments in a setting that
reflects this morphological complexity.
Studies have shown that intracanal medicament, which is placed as a temporary
filling before the root is permanently filled, significantly decreases the presence of
intracanal bacteria and therefore may lead to better treatment outcomes (Siqueira
et al., 2007b,a). Calcium hydroxide (Ca(OH)2) is primarily used as an intracanal
medicament, however there are limitations in its use. Its mode of action is raising
the pH of the root in order to kill bacteria, but this effect is buffered by dentine
proteins and carbonate ions, lowering the effective pH to around 10 (Athanassiadis
et al., 2009). This can be withstood by some fungal species, and by the bacterium
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E. faecalis, which is commonly isolated from secondary root infections (Ferguson
et al., 2002; Mohammadi and Dummer, 2011).
This chapter will consider the use of a triclosan/liposome loaded hydrogel as an
intracanal medicament for endodontic infection, using extracted human teeth as a
model system. It will assess the hydrogel’s efficacy in preventing E. faecalis invasion
of the root canal space, following pre-culture of the tooth with the bacteria.
5.2 Materials and methods
5.2.1 Preparation of liposomes and liposome-loaded methyl
cellulose
Multilamellar vesicle (MLV) liposomes were prepared with 300 µg/mL triclosan and
1 mg/mL phosphatidylcholine:cholesterol (mass ratio 7:1), as described in Chapter
3, Section 3.2.1 and defined as T300 MLVs.
The T300 MLVs were incorporated into a 10 % (w/w) methyl cellulose (MC)
solution, as detailed in Chapter 4, Section 4.2.1.2. Control MC solution was prepared
containing H2O only.
5.2.2 Sample collection of human incisors and premolars
Following ethical approval, human incisors and pre molars were collected from Cardiff
University School of Dentistry Tooth Bank (REC reference 12/WA/0289, project
reference TB-14-008, approved on 08/01/2015). Teeth had been extracted for non-
orthodontic reasons and were stored at -80 ◦C prior to use. Ten teeth were collected
in total.
5.2.3 Endodontic preparation of extracted teeth
Teeth were prepared by a clinically qualified dentist. All teeth were radiographically
examined using horizontal parallax technique to visualise root canal anatomy and
estimate working length prior to preparation. Access cavities were prepared through
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the occlusal surface using a diamond bur (501 HiDi, Dentsply Limited, Surrey, UK)
with water coolant. Refinement of pulp chamber outline and enlargement of root
canal orifices was achieved using an ultrasonic instrument without water coolant (P5
Newtron XS, Acteon, UK). Subsequently, canals were prepared using size 10, 15 and
20 stainless steel K-files (Dentsply Maillefer, Ballaigues, Switzerland). Where deemed
necessary to improve preparation, coronal flaring of canals was undertaken using a
rotary, nickel-titanium ProTaper SX file (Dentsply Limited, Surrey, UK), followed by
the S1, S2, F1, and F2 files according to the manufacturer’s instructions. After each
file was used, the canal was irrigated with 2 % (w/v) sodium hypochlorite solution
and recapitulated using a size 10 K-file to ensure apical patency.
Following instrumentation with the S1 rotary file, teeth were placed in alginate
impression material to simulate periapical tissues, and an electronic apex locator
(Mini Apex Locator, Kerr UK Limited, Uxbridge, UK) used to confirm the working
length. After preparation was completed, canals were irrigated using 17 % (w/v)
ethylenediaminetetraacetic acid (EDTA) solution and final irrigation using 0.9 %
(w/v) sodium chloride solution to remove debris and any residual antimicrobial agents
from prior irrigation. Radiographic examination was repeated following preparation
to confirm adequate preparation quality. 1
5.2.4 Infection and treatment of root canals
After endodontic preparation, teeth were exposed to 9100 cGy gamma irradiation
over 40 min (Gamacell 1000 Elite, Noridon International inc., Oxfordshire, UK ) to
sterilise and then incubated overnight in brain heart infusion (BHI) broth to confirm
effective sterilisation. If the BHI became turbid, indicating bacterial growth, the
tooth was excluded from the experiment.
Teeth were placed in a sterile 1.5 mL microcentrifuge tube with the bottom cut
away. The tube was then positioned inside a bijou tube containig 2.5 mL BHI so
that the root apex was submerged. This arrangement is illustrated in Figure 5.1. An
overnight culture of E. faecalis was diluted in BHI to obtain an absorbance value of
1Section 5.2.3 provided by Joshua Twigg
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Figure 5.1: Culture setup of tooth for infection model (Section 5.2.4).
0.08-0.1 at 600 nm. Two further 10-fold dilutions were prepared and the resulting
bacterial suspension was injected into the roots using a 21 gauge needle. The teeth
were incubated for 24-48 h at 37 ◦C in 5 % CO2. A control tooth was prepared with
no bacterial inoculation.
The teeth were then washed in sterile phosphate-buffered saline (PBS), in order
to remove any non-adherent bacteria, and placed into a fresh bijou containing BHI,
as before. The roots were dried with sterile paper points, which were streaked onto
a tryptone soya agar (TSA) plate to confirm that the roots were infected. Treatment
was then applied to the roots using a 21 gauge needle as follows:
A BHI only (no initial bacterial inoculation),
B BHI only (with initial bacterial inoculation),*
C triclosan solution (200 µg/mL in 1 % IPA),*
D triclosan liposomes (T300 MLVs),
E triclosan liposomes in MC (T300 MLVs in 10 % w/w MC),
F MC in H2O (10 % w/w).
*Conditions B and C were performed on a seperate occasion to others.
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The teeth were then incubated with the treatment for a further 24 h at 37 ◦C in
5 % CO2.
5.2.5 Histological prepartion of samples
5.2.5.1 Fixation and demineralisation
Teeth were removed from culture and placed in 10 % (v/v) neutral-buffered formalin
solution for 48 h in order to fix the tissues. The teeth were then transferred to 15
% (v/v) formic acid for 14 days for tissue demineralisation to occur. During this
time, the samples were removed and placed into fresh formic acid every 48 h. After
demineralisation, the teeth were cut longitudinally with a scalpel and placed in a
biopsy cassette.
5.2.5.2 Automated tissue processing and paraffin wax embedding
Samples were processed through graded chemicals on an automatic tissue processor,
as follows:
1. 70 % ethanol, 1 h,
2. 90% ethanol, 1 h,
3. 100 % ethanol, 1.5 h,
4. 100 % ethanol, 1.5 h,
5. 100 % ethanol, 1.5 h,
6. 100 % ethanol, 1.5 h,
7. Xylene, 1.75 h,
8. Xylene, 1.75 h,
9. Xylene, 1.5 hr,
10. Molten wax, 2.5 h, 60-65 ◦C,
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11. Molten wax, 2.5 h, 60-65 ◦C.
Following processing the tissues were embedded in paraffin wax using a processing
machine (Shandon Pathcentre, Thermo Scientific, Surrey, UK) and aligned so that
longitudinal sections of the teeth could be cut.
5.2.5.3 Sample sectioning
Sections of 6 µm thickness were cut from the wax blocks using a Leitz 1400 microtome
(Leica, Buckingham shire, UK). The embedded sections were floated on H2O (40
◦C)
and mounted on polylysine glass slides. Slides were placed at 60 ◦C for at least 1 h
to allow for adhesion of the sample to the slide. The slides were then stained.
5.2.5.4 Haemotoxilyn and eosin staining
Slides were placed on an automated tissue stainer. The slides were taken through
xylene, ethanol and water washes followed by haemotoxylin and eosin (H&E) stains.
They were then taken through a further series of alcohol washes before finally being
immersed in xylene. The slides were then removed and a coverslip was applied with
DPX mountant.
5.2.5.5 Gram stain
Sections, mounted on slides, were sequentially submerged xylene, 99 % ethanol, and
distilled H2O for 5 min each. After flushing with crystal violet solution for 60 s,
samples were rinsed with tap water and then flushed with Lugoli’s iodine solution
for 60 s. Acetone was used to rinse the slide until the acetone ran clear and then
the slide was rinsed with tap water before Carbol fuchsin solution was applied for
60 s. The slide was then rinsed with tap water once more, left to air-dry, and then
submerged in xylene for 5 min before a cover slip was applied with DPX mountant.
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5.2.6 Imaging and analysis
Slides were scanned with an Aperio slide scanner and viewed using Aperio ImageScope
software (Leica Biosystems, Buckinghamshire, UK). Representative images of each
slide were taken at 20 X magnification. Images were taken of root interior, where the
dentine tubules were observed to be perpendicular to the root surface.
Slides of Gram-stained sections were also viewed under oil immersion light mi-
croscopy at 100 X magnification (Nikon Eclipse 50i, Nikon Instruments, Amsterdam,
Netherlands) and viewed using StCamSWare (Omron SenTech,Kanagawa, Japan) to
view bacterial morphology.
5.3 Results
5.3.1 Tooth collection and preparation
Out of the 10 teeth collected, 4 were excluded from the experiment: one had a root
fracture and was not suitable for endodontic preparation. The other 3 were not sterile
following irradiation, indicated by the criteria set out in Section 5.2.4. Radiographs
of the 6 teeth included in the experiment before and after endodontic preparation are
shown in Figure 5.2. Each tooth was a premolar with single or double root canal.
Some had an intact crown (2 and 6), one had no crown (3), and the others (1, 4 and
5) had evidence of caries and/or previous restoration that required removal.
5.3.2 Bacterial inoculation of teeth
Following incubation with E. faecalis and then washing with PBS, the root canals
were dried and swabbed onto TSA. All swabs were positive for bacterial growth, apart
from the sterile control that had not been inoculated with the bacterial suspension,
confirming that the root canals had been successfully infected with E. faecalis prior
to treatment (Table 5.1).
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Figure 5.2: Radiographs taken of extracted teeth using horizontal parallax technique.
Images show radiographs of 6 teeth (1-6) before (A+B) and after (C+D) endodontic prepa-
ration.
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Table 5.1: Growth of swabs taken from endodontically prepared teeth fol-
lowing 24-48 h bacterial inoculation.
Extracted teeth were endodontically prepared, sterilised, and the root canals inoculated with
E. faecalis for 24-48 h. Root canals were then rinsed and dried before swabs were taken
and streaked onto TSA plates. Table shows whether bacterial growth was positive or
negative for each tooth swabbed (A-F).
5.3.3 Histology sections: H&E staining
Histological sections of the infected and treated teeth were prepared and stained
with H&E, which stains anionic structures blue and cationic structures pink, allowing
clearer visualisation of tissues.
In all sections, the root dentine was identified as being stained pink, with the
tubules being visible at a perpendicular angle to the intraroot surface. Some blue
staining was observed along the tubules (Figure 5.3A-F).
In some sections, additional purple-stained structures were identified on the in-
traroot surfaces, which were believed to be evidence of a biofilm, due to the presence
of dark, granular clusters that were consistent with bacterial cells and not present on
the bacteria-free control (Figure 5.3A). This was particularly evident in samples B
(no treatment, Figure 5.3B) and F (treated with MC in H2O, Figure 5.3F).
These data suggest that a biofilm had formed on intraroot surfaces of teeth with
no treatment or treated with the MC in H2O control (Figure 5.3A and F). Teeth that
were treated with triclosan solution, triclosan liposomes, and triclosan liposomes in
MC, did not have evidence of biofilm formation (Figure 5.3B-E) and appeared more
similar to the non-infected control (Figure 5.3A).
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Figure 5.3: H&E stained sections of human teeth treated with antimicrobial
hydrogel. Teeth were inoculated with E. faecalis suspension and then treated with: A
BHI only (no initial bacterial inoculation); B BHI only (with initial bacterial inoculation);
C triclosan solution (200 µg/mL in 1 % IPA); D triclosan liposomes (T300 MLVs); E
triclosan liposomes in MC (T300 MLVs in 10 % w/w MC); F MC in H2O. Teeth were
fixed and sectioned and representative images are shown of root surface appearance after
H&E staining (X20 magnification). Blue arrows indicate areas of possible biofilm formation
(Section 5.3.3).
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5.3.4 Histology sections: Gram-staining
Sections were treated with Gram stain, which stains Gram-positive bacteria pur-
ple (crystal violet), and Gram-negative bacteria and other structures pink (fuchsin).
E. faecalis cells are Gram-positive cocci, as shown in Chapter 2, Figure 2.3.
Gram stains showed pink staining of dentine tissues, with dark purple staining
suggesting the presence of Gram-positive bacteria along the dentine tubules (Figure
5.4A-F). All samples showed some positive staining from Gram-positive bacteria,
including the tooth that was not inoculated with E. faecalis following sterilisation
(Figure 5.4A). This suggests that the teeth contained residual bacterial infection prior
to the experimental procedure. The tooth that was inoculated with E. faecalis and
not treated showed material on the root surface containing Gram-positive staining
that was consistent with the presence of a bacterial biofilm (Figure 5.4B). This was
not as clearly present in other samples apart from the tooth treated with MC alone,
which showed some evidence of biofilm presence on the root surface (Figure 5.4F).
Images of Gram-stained sections were taken at 100 X magnification in order to
identify bacterial morphology in these sections (Figure 5.5). In the previously identi-
fied biofilms, evidence of Gram-positive cocci was seen: either as single cells, chains,
or clusters. These are identified by blue arrows in Figure 5.5B and F. In all sam-
ples, some evidence of bacterial cocci, chains or clusters was observed in the dentine
tubules (also denoted by blue arrows in Figure 5.5A-F), however these were not as
clear.
Results of Gram stain imaging agreed with those of the H&E stain images and
suggested the presence of a biofilm containing gram-positive cocci on the root surface
of the tooth that was infected and left untreated as well as the tooth treated with
MC in H2O.
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Figure 5.4: Gram stained sections of human teeth treated with antimicrobial
hydrogel. Teeth were inoculated with E. faecalis suspension and then treated with: A
BHI only (no initial bacterial inoculation); B BHI only (with initial bacterial inoculation);
C triclosan solution (200 µg/mL in 1 % IPA); D triclosan liposomes (T300 MLVs); E
triclosan liposomes in MC (T300 MLVs in 10 % w/w MC); F MC in H2O. Teeth were fixed
and sectioned and representative images are shown of root surface appearance after Gram-
staining (X20 magnification). Black arrows indicate areas of possible biofilm formation
(Section 5.3.4).
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Figure 5.5: Gram stained sections of human teeth treated with antimicrobial
hydrogel. Teeth were inoculated with E. faecalis suspension and then treated with: A
BHI only (no initial bacterial inoculation); B BHI only (with initial bacterial inoculation);
C triclosan solution (200 µg/mL in 1 % IPA); D triclosan liposomes (T300 MLVs); E
triclosan liposomes in MC (T300 MLVs in 10 % w/w MC); F MC in H2O. Teeth were
fixed and sectioned and representative images are shown of root surface appearance after
Gram-staining (X100 magnification). Blue arrows indicate possible single cells, chains or
clusters of gram positive bacteria (Section 5.3.4).
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5.4 Discussion
This preliminary experiment aimed to assess the efficacy of the previously developed
MC hydrogel containing triclosan liposomes (T300 MLVs) in a clinically relevant
setting. The data shown suggest that the hydrogel prevented the formation of a single-
species E. faecalis biofilm on the intraroot surface of pre-infected human teeth. It is
proposed that this is through the exposure of bacteria that has been introduced to the
root canal to triclosan that has been released from the hydrogel, and has an inhibitory
effect on further E. faecalis growth, as demonstrated in previous chapters. This
prevention was also seen when triclosan solution and T300 MLV liposomal suspensions
were used. Although triclosan solution and T300 MLV suspension showed prevention
of E. faecalis growth, the use of a liquid would not be practical as a medicament
as it would not be retained within the root canal due to potential leakage through
the apical foramen (Bosch-Aranda et al., 2012) and would be particularly difficult to
apply to maxillary (upper) teeth as they would flow out through the coronal access
due to gravity. Further investigation could be made, however, into their potential use
as a root canal irrigant.
The efficacy of the T300 MLV in MC over 24 h is promising, however an intra-
canal medicament would typically be placed for 14-28 days between appointments
(Athanassiadis et al., 2007). Ca(OH)2 paste, which is the current gold standard, was
shown by Bitter et al. (2017) to be bactericidal against E. faecalis after 7 days ex
vivo culture in a canine root canal inoculated with the bacterium (i.e. no culturable
bacteria were recovered from the root canal after this time). A similar study by
Vivacqua-Gomes et al. (2005), however, showed that E. faecalis was recovered from
25 % of teeth that had been inoculated with the bacterium, endodontically prepared,
and treated with Ca(OH)2 for 14 days. It would therefore be advantageous to extend
the incubation time with treatment to 7, 14 and 28 days to test the longer-term
efficacy of the material.
The methodology used in this chapter allowed for the identification of Gram-
positive bacteria in the dental root. If Gram-negative bacteria were to be investigated,
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it would be preferable to reduce the level of background fuchsin staining by using a
modified Gram stain such as the Brown and Brenn method, in order to counter-
stain the tissues against the bacteria (Dee Taylor, 1966). This method includes
an additional picric acid/acetone wash, which results in a yellow counterstaining of
tissues and a higher contrast against the pink or blue-stained bacteria.
One of the key disadvantages of many current endodontic disinfection methods
and materials is the difficulty in accessing bacteria that reside in the dentine tubules
(Wright and Walsh, 2017). In this study, bacteria appeared to be present in the
dentine tubules of all samples, including the sterile control, suggesting a background
level of contamination was present before the in vitro introduction of E. faecalis to the
teeth. Although this contamination was eliminated by irradiation of the tooth before
the experimental procedure, the analytical methodology used could not distinguish
between live and dead bacteria. It was therefore not possible to differentiate between:
• background contamination, i.e. bacteria that was already present in the col-
lected extracted tooth and then killed by irradiation prior to the experimental
inoculation with E. faecalis,
• experimentally introduced E. faecalis that had colonised the dentine and re-
mained alive even after treatment,
• experimentally introduced E. faecalis that had colonised the dentine and sub-
sequently killed by the treatment.
It was not therefore possible to ascertain the material’s efficacy in eliminating
bacteria from dentine tubules using this methodology. Other methodology may pre-
serve live bacteria, for example Azim et al. (2016) investigated the efficacy of root
canal irrigation techniques by inoculating extracted tooth root canals with E. fae-
calis and, after administering the irrigation treatment, splitting the tooth in half
longitudinally and then applying a live/dead fluorescent stain to be imaged using
confocal microscopy. This technique distinguished between live and dead bacteria
along the dentine tubules and allowed for an estimation of the penetration depth of
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the administered antimicrobial irrigant. A similar methodology could be employed
in the future to assess whether the gel not only prevents bacterial colonisation of the
intraroot surface, but also kills bacteria residing in dentine tubules.
Although the rheological properties of the hydrogel have previously been char-
acterised, it is unknown whether these properties are optimal for ensuring that the
root canal is effectively filled upon injection, as discussed in Chapter 4, Section 4.4.
The methodology used here did not keep the gel intact within the root in order to
assess this: fixation and demineralisation processes were performed at ambient tem-
perature, allowing for reversal of MC gelation and subsequent dilution out of the root
canal. Future work aims to address this research question, which could be achieved
by maintaining the tooth at 37 ◦C during the fixation process in order to preserve the
hydrogel structure for histological analyses. Alternatively, a radio-opaque compound
could be introduced to the gel in order to assess its filling efficacy by radiographic
techniques. Simcock and Hicks (2006) obtained radiographic images of roots filled
with Ca(OH)2 using different filling techniques, which were assessed by independent
examiners and scored (1-10) for filling quality. Additionally a comparison of the
weight of Ca(OH)2 in an “optimally filled” root compared to the weight in the exper-
imentally filled roots gave quantitative data to assess filling efficacy, which correlated
with the radiograph scores and confirmed that injection was the most effective deliv-
ery method. Jung et al. (2005) compared micro-computed tomography (micro-CT)
3D reconstructions to histological samples of root canals obturated with gutta-percha
cones and concluded that there was a good correlation in results between the two tech-
niques and that micro-CT could potentially be used to assess the filling efficacy of
other materials.
Teeth were incubated at physiological temperature in 5 % CO2 for this study and
the root apex was submerged in BHI to allow bacteria access to a high-nutrient envi-
ronment. E. faecalis forms biofilms with different properties, depending on whether
conditions are aerobic or anaerobic, as well as the availability of nutrients to the
bacteria (George et al., 2005). It may be clinically more relevant to perform the
experiment under anaerobic, low nutrient conditions, to mimic the biological setting
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(Narayanan and Vaishnavi, 2010). This could be achieved by incubating the tooth
in an anaerobic chamber and replacing the BHI with a lower-nutrient medium (e.g.
by using buffered saline).
Experimental variation is introduced when using extracted teeth, as the individual
root anatomy is inherently variable and an increase in anatomical complexity of
the root canal system has been shown to correlate with the occurence of secondary
endodontic infection, potentially due to the difficulty of root preparation (Vertucci,
2005). This was somewhat controlled for by the experimental design, as the teeth
carried no residual infection after preparation, due to the irradiation of the samples
prior to introducing E. faecalis culture. In addition, the use of extracted teeth allowed
the clinician to adopt optimal working conditions for tooth preparation, and factors
such as tooth position in the oral cavity and patient compliance were eliminated.
Dentine anatomy varies due to a number of factors including patient age and pre-
vious trauma, which will result in the presence of tertiary dentine that has anatomical
differences to primary and secondary dentine (Chapter 1, Section 1.2.5.1). Tertiary,
or sclerotic dentine with no tubules can physically impede bacterial colonisation of
the dentine (Love, 2004). This may influence the degree of biofilm formation on the
intraroot surface as well as the biomass of bacteria residing in dentine tubules fol-
lowing the initial inoculation and removal of non-adherent cells. These experiments
would therefore need to be repeated before drawing firm conclusions from these data.
The current results, however, provide promising evidence that the liposomal hydrogel
has good efficacy against E. faecalis in an ex vivo model of endodontic infection.
5.5 Conclusions
These preliminary data suggest that MC hydrogel containg T300 MLV liposomes
prevents the colonisation and biofilm formation of E. faecalis in pre-infected human
root canals that have undergone endodontic preparation. Future work aims to assess
the efficacy of the gel in the dentinal tubules as well as the filling efficacy of the gel
in the intraroot space.
Chapter 6
General Summary and Future
Direction
The aim of this project was to develop a material for antimicrobial drug delivery in
the dental cavity. In particular, the target material was considered as an intracanal
medicament for the prevention of secondary endodontic infection. Such materials
are already used in the clinic, with Ca(OH)2 being the most widely used intracanal
medicament, however a proportion of endodontic treatments still fail due to secondary
microbial infection. There was therefore a clinical need identified to improve upon
the process of bacterial eradication from dental root canals. The proposed material
comprised of three main components: triclosan, which is a hydrophobic, antimicrobial
drug; liposomes composed of phosphatidylcholine and cholesterol, for the potential
encapsualtion and delivery of the antimicrobial; and a methyl cellulose (MC) hydrogel
to carry and deliver the drug-loaded liposomes in the dental root canal.
Triclosan was selected as a broad-spectrum antimicrobial that is already widely
used in oral health products. Its efficacy against streptococci and Enterecoccos spp.
has previously been reported by others, and was demonstrated in this work to have a
concentration-dependent inhibitory and biocidal effect on clinical strains of E. faecalis
and S. anginosus when grown planktonically or as a single-species biofilm. Liposomal
drug encapsulation had been shown by others to mediate effective, prolonged drug
delivery and enhanced drug potency in some cases (Lian and Ho, 2001; Samad et al.,
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2007), so it was investigated whether it would be suitable to load the triclosan into an
aqueous suspension of liposomes, and whether this showed any advantages over tri-
closan in solution. Triclosan retained its antimicrobial properties when incorporated
into liposomes, and in some instances appeared effective at concentrations below the
previously ascertained MIC (in the case of T300 SUVs). This suggests that liposomal
encapsulation may increase drug potency of triclosan, which has also been reported
by others: El-Zawawy et al. (2015) observed improved efficacy of triclosan liposomes
in vivo against Toxoplasma gondii when compared to triclosan in solution.
Unlike triclosan in solution, liposomal triclosan efficacy was not solely dependent
on the absolute triclosan concentration of the suspension. It was observed that the
drug:lipid ratio of the liposomes may also play a role in the efficacy of the liposomes.
This was achieved by increasing the initial amount of triclosan added to the liposome
preparation, and it was found that a starting concentration of 300µg/mL (T300)
resulted in a high drug:lipid ratio compared to T50 and T100 liposomes, and that
these T300 liposomes had the greatest antimicrobial effect. These data imply that
liposomal triclosan delivery is not a passive process (i.e. with triclosan simply being
released into the surrounding aqueous suspension) but an interactive process between
the liposomes and bacterial cells. Two mechanisms of liposomal delivery to microbes
have been proposed previously in the literature: either by fusion of liposomes to the
bacterial cell wall/membrane and release of their contents directly to the bacterium;
or by binding of the liposomes to the bacterium, serving as a “drug depot” that
continuously releases the drug, resulting in a higher local concentration surrounding
the bacterium compared to the absolute concentration of the system (Zhang et al.,
2010). Future work should aim to elucidate the mechanism by which triclosan lipo-
somes deliver their cargo to the bacteria, potentially through electron microscopy,
to assess co-localisation of the bacteria and the liposomes (Mugabe et al., 2006), or
through differential fluorescent labelling of the bacteria and liposomes in order to
assess membrane fusion through fluorescence spectroscopy (Hoekstra et al., 1984).
Incorporation of T300 and T500 triclosan liposomes into a MC hydrogel resulted
in similar antimicrobial properties of the liposome suspensions, with slightly lower
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efficacy. This could be related to the release properties of the MC hydrogel, which
showed that only 20 % of triclosan was released from the gel over 24 h, meaning it is
possible that the bacteria were exposed to a lower concentration of the drug during
this time period. Gels containing triclosan alone did not result in any triclosan release.
This was supported by the fact that triclosan in MC had no antimicrobial effect
against E. faecalis and S. anginosus, despite the fact that the equivalent concentration
was both bacteriostatic and bactericidal in solution. This suggests that liposome
encapsulation is essential for allowing the release of triclosan from the gel. Triclosan
solutions used for the initial antimicrobial assays (Chapter 2) contained 1 % IPA to
facilitate triclosan dissolution. This was not included in the release assay, as it was
preferable to have a direct comparison with liposomal triclosan, which is prepared
only in water. The triclosan in MC prepared for the antimicrobial assays, however,
did contain IPA, and an antimicrobial effect was still not observed, showing that
solvent addition is not sufficient to obtain the same triclosan release and efficacy as
liposomal encapsulation when considering delivery by a MC hydrogel.
Rheological analyses of MC solutions containing triclosan liposomes suggested
that the physical properties may be desirable for injection in the root canal , however
this was not directly assessed. Future work should demonstrate the depth of gel
penetration into the root cavity and relate this to its rheological properties. Methods
for such analyses include the incorporation of a dye into the gel so penetration can
be viewed microscopically (Weis et al., 2004) and microCT analysis (Swain and Xue,
2009). Qualitative analysis showed that incubation of human teeth following injection
of the gel into the root canal resulted in a prevention of a biofilm growth of E. faecalis.
This provides indirect evidence that the physical properties are sufficient to allow MC
penetration into root canals and that the composite system has a potentially useful
effect on bacterial activity on the intraroot surface. The capacity of the material to
penetrate into dentine tubules was not assessed, nor was the antimicrobial activity
against bacteria that may reside in these tubules. The same microscopy and contrast
tomography methods would be applicable to assess this and this may contribute to an
understanding of the optimal rheological properties required for effective root canal
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medicament delivery, which are not currently available in the literature.
The two bacterial strains selected for antimicrobial testing in this work were cho-
sen on the basis of applying the developed material to pulpal and endodontic infec-
tions, in which S. anginosus group bacteria and E. faecalis are widely implicated.
E. faecalis was used in the human endodontic infection model as it is associated
with cases of failed endodontic treatment and so the efficacy of this material against
that particular species was considered important. Triclosan is a broad-spectrum an-
timicrobial, and so the hydrogel may be applicable to other oral clinical settings.
Additionally, the gel was not tested on a vital pulp model of dental infection, and
so this could be explored in order to assess the gel’s potential application in vital
pulp therapy and/or pulp capping. This could be done using previously developed
pulpal infection models, which have already been used to determine the effect of free
triclosan on S. anginosus infection of rat pulp cells (Roberts et al., 2013c). Periodon-
titis is another plaque-related oral disease that results in the degradation of tissue
surrounding the tooth exterior. Antimicrobial medicaments may be placed in peri-
odontal “pockets”, or voids between the tooth and the gingiva where periodontitis
has occurred (Vyas et al., 2000) and so the physical and antimicrobial properties
of the gel could be assessed for this application with the potential to optimise the
material properties for this alternative oral location.
In conclusion, a novel antimicrobial composite gel system was developed that
showed promising results in the prevention of oral microbial infection, particularly
in the case of E. faecalis infection in dental root canals. The further development
and use of this material as an intracanal medicament may result in the reduction of
secondary, progressive endodontic infections where E. faecalis is the main pathogen,
thus reducing the need for additional and more complex treatment in some patients.
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Appendix A
Protocol used for bacterial DNA
extraction
Extract taken from QIAmp DNA Mini and Blood Mini Handbook. Full handbook available
at: https://www.qiagen.com/gb/shop/sample-technologies/dna/genomic-dna/qiaamp-dna-
mini-kit/#resources - accessed 30/05/2017.
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Appendix B
DNA sequences of 16S rRNA
region of E. faecalis and S.
anginosus
E. faecalis RB17
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Appendix C
Phospholipid assay protocol
Accessed from:
http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Bulletin/2/mak122bul.pdf
- 13/11/2017.
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